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5Abstract
The development of clinical treatment protocols for particle therapy depends
on the availability and quality of radiobiological data. Studying available
commercial and in-house phantoms, showed that the current solutions either
lack dosimetry or this dosimetry introduces uncertainties to the biological
results. Therefore new radiobiological tools with improved dosimetry response
were required. The chosen material, the effect of detectors uncertainties and
the impact of detectors? positions were studied so the effect of the introduced
uncertainties in the measurements could be evaluated. The phantom was
subsequently tested at different experiments with both protons and carbon ion
beams where a number of dose fields were simulated and delivered. Simulated
and measured doses were compared to establish accuracy of simulation. Finally,
a clonogenic survival assay was performed to assess the viability and capabilities
of the phantom. No disturbance was introduced in the cell region by the
detectors where 95.3% of the cases were within the 95% confidence level.
Additionally, the detector measurements were free from any disturbance arising
from the adjacent detectors (sigma 0.76). When evaluating the simulation
accuracy, a good agreement was obtained between measurements and dose
modelling where the average dose deviation was between 1.05% and 2.39%.
Superior effectiveness was obtained for protons and carbon ions in respect
to X-rays (1.2 and 2 times for protons and carbon ions respectively) and the
phantom was able to correlate the cell survival and dose deposition. Concluding,
these results showed that the phantom limitations were accounted for which
enabled the measured physical dose and the dosimetry in the cell compartment
to be correctly correlated. The results demonstrate the superior dosimetry
obtained in respect to other set-ups either by correctly describing the dose
profile (additional 1.5% mean deviation due to dose delivery uncertainties) or
by not introducing uncertainties in the beam path (up to ± 2%).
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Chapter 1
Introduction
1.1 Aim
This chapter aims to provide the contextual background for the thesis. After a
brief introduction of the principles of Hadron Therapy (HT) and its current
status, the role of radiobiology in the patient dose calculation and its importance
in Hadron Therapy will be considered.
1.2 Introduction to Hadron Therapy
Radiotherapy with protons or ions, also called Hadron Therapy, Particle
Therapy or Ion Beam Therapy is, in principle, able to target the tumour
more effectively while sparing surrounding normal tissues. Due to its physical
properties (see section 1.2.1 below), ions can play an important part in providing
good tumour/dose conformity while reducing the integral dose. The idea of
using the superior depth dose for ions in relation to photons in medicine was
first introduced by Robert Wilson (Wilson 1946). This concept is shown in
Figure 1.1, which compares the difference between the energy deposition in
relation to the depth for ions and electromagnetic radiation. Because ions
have a defined range, they are the perfect candidate for treating deep-seated
tumours and sparing organs and structures seated near the tumour site.
A further favourable factor for the use of ions in therapy are their improved
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biological efficiency in cell killing (see section 1.2.2 below). This fact reiterates
the importance of high precision in the dose delivery as this improved efficiency
also affects the surrounding normal tissues (Schulz-Ertner et al. 2006). This
improved efficiency is mainly owing to the increased ionisation density along the
individual tracks of the ions, which introduces more clustered Deoxyribonucleic
acid (DNA) damage, making it more difficult for the cell to repair (Kraft 2000).
Besides the reduced repairability, ions are also expected to be less susceptible to
biological characteristics known to reduce the sensitivity to radiation damages
like the oxygenation level (Churchill-Davidson 1966) and cell cycle.
In addition to the presented positive aspects, the use of ions also presents
some disadvantages. These are associated to range calculation uncertainties
(Paganetti et al. 2002) and the errors associated with modelling biological
efficiency and its translation into the calculated biological dose (Boehlen et al.
2012). The calculated biological dose is affected by either the dose calculation
models (Paganetti et al. 2002; Carabe et al. 2012; Boehlen et al. 2012), or
the uniqueness of the particle accelerator/dose delivery systems used (Rossi
2011). Tools to aid with the study of biological responses in conjunction with
dosimetric information still need to be further developed in order to translate
these findings into clinical practice and to help compare multi-centre systems.
1.2.1 Physical Properties
As described above, the energy deposition in matter by an ion is inversely
proportional to its velocity, allowing a small deposition at the beam entrance
and high deposition at the end of its path (known as Bragg Peak (BP), which
can be seen in Figure 1.1 in relation to other radiation types). In the clinical
scenario, since the width of the BP is smaller than the width of the tumour
and its position is related to the initial kinetic energy of the beam, it is possible
to arrange a combination of different peaks to cover the whole extent of the
tumour (called Spread-out Bragg Peak (SOBP)).
Compared to ions, electromagnetic radiation interacts with the matter
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by stochastic processes (mainly Photoeletric and Compton) that yield an
exponential decay of absorbed dose with penetration (Kraft 2000). Around
the clinical energies (circa hundreds of MeV), the energy loss of ions is mainly
influenced by the electronic collision, which can be described by the Bethe-Bloch
formula:
dE
dx
=
4piZ2effe4ZN
mev2
ln 2mv
2
I
+ relativistic terms (1.1)
Where dE
dx
is the energy loss per length, Z is the target atomic number, N
the electron density of the target, me and e the mass and charge of the electron,
v = βc the projectile velocity and I is the mean ionisation potential. Zeff
corresponds to the effective projectile charge which can be approximated by
the Barkas formula:
Zeff ' Z(1− exp−125βZ 23 ) (1.2)
The Bethe-Bloch equation is strongly shaped by the 1
v2 and Zeft dependency
that provides the increase of dose deposition at the end of the particle’s path
where its velocity is smaller.
Linear Energy Transfer (LET)
The rate of loss of energy, known as the Linear Energy Transfer (LET), depends
on the energy and type of radiation as well as the material. LET is described
as the average energy deposited per unit of track length of radiation. Its unit
of measurement is keV/µm. As the ion beam loses its energy along its path,
the rate of the energy loss, as described above (Equation 1.1) will increase, and
therefore the LET increases as the particle continues to slows down.
Hence, the increased LET at the end of the particles’ track. The use of LET
to describe the density of ionisation is especially important to understand the
biological effects of radiation. This happens because the different effectiveness
of different radiations are dependent on the radiation’s type and LET. Usually,
directly ionising radiation (charged particles) have higher LET than indirectly
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Figure 1.1. Comparison of the depth dose profiles for different particle types (Kraft
2000).
ionising radiation (X and γ rays) because of their greater energy deposition
along the track (IAEA 2010).
Absorbed dose
The amount of energy absorbed per mass is known as the radiation dose. The
Radiation dose is the energy (Joules) absorbed per unit mass of tissue and has
the (S.I.) units of gray (1 Gy = 1 J/kg) (IAEA 2010).
1.2.2 Biological Properties
The biological effects are directly related to the DNA damage produced by
the ionising effects in the target cell. This DNA damage can occur directly or
indirectly, from either the ionisation or the excitation of the atoms belonging
to the DNA, or from the products of the interaction of the radiation with the
atoms and molecules other than the constituents of DNA.
The pattern in which radiation ionises the cell is described by the LET, and
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particles with higher LET are associated with having greater energy deposition
and therefore greater DNA damage. In comparison to X-ray, which is considered
a low-LET radiation, ions will more often produce damage of the DNA structure
within one cell which is more difficult to be repaired (Goodhead 1999). LET is a
characteristic related to the radiation type that describes the energy deposited
per unity of distance (normally expressed in keV/µm) and is commonly used
to compare biological effects from different radiation types (Kraft et al. 1992;
Zirkle 1954).
Relative Biological Effectiveness (RBE)
In order to quantify these effects and compare them with other radiation
treatment modalities, the additional biological effect needs to be measured
in a meaningful way such as a dose equivalent increment or factor. This is
conceptualised as the relative biological effect (RBE), and in practice the
RBE-weighted dose, used clinically for patient treatments, is the product of
the absorbed dose and RBE. RBE compares the biological effect observed
with a radiation type to a reference radiation in order to produce the same
biological effect (Equation 1.3). Figure 1.2 shows the survival curves for the
RAT-1 (dunning rat prostate cancer cells) cell line for both X-rays and carbon
ions and the calculated RBE10, which represents the ratio of dose between
the different radiation types required to achieve the same cell survival of 10%
(Tinganelli et al. 2013).
To compare the effectiveness of different ionising particles, the RBE has
been defined. It is the ratio between the dose absorbed from the γ decay of
60Co needed to produce the wanted outcome and the dose of the radiation
under study (IAEA 2000), needed to produce the same consequence:
RBE =
D(γ60Co)
D(test)

isoeffect
. (1.3)
RBE is a combination of a physical effect, namely the ionisation density,
and of a biological phenomenon, that is the DNA repair capacity of the cell. In
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general, RBE increases with the increase of the radiation LET up to a value
of around 100 keV/µm and above this value starts to decline due to energy
deposition in excess of that needed to cause the biological effect (overkill) as
seen in Figure 1.3. Energy loss events are essentially randomly distributed
along the track of the photon or charged particle. For low LET radiations the
energy deposition events along the track are sparse relative to the dimensions
of biomolecules such as DNA with the result that photons may pass through
such a molecule without depositing any energy. For high LET radiation the
energy loss events are much more closely spaced and significant energy similar
in dimension to biomolecules will be deposited along all parts of the track
(IAEA 2010).
Figure 1.2. Cell survival curves for RAT-1 rat prostate cancer cells irradiated with
carbon ions and X-rays (LET 150 keV/µm for carbon ion beam and X-rays from
an Isovolt DS1 X-Ray machine at 250 kVp and 16mA). Data from Tinganelli et
al. with kind permission (Tinganelli et al. 2013). The horizontal lines follow the
10% isoeffect level and the vertical line follow the dose required for this isoeffect.
The RBE10 is the ratio of these doses. In this case the RBE10 is the ratio of the
dose 6.77 by 2.41 resulting in a RBE10 of 2.81.
RBE is used in the treatment planning process (the biological dose given to
the patient is the dose of reference radiation divided by RBE for the particle
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used in the treatment), so over-estimation of RBE could result in reduced
tumour control since the physical dose given to a patient is over-reduced.
Similarly, under-estimation of RBE in normal tissues could cause excess side
effects. In the experimental determination of RBE, the natural variations
associated with living organisms must be separated from the uncertainties
introduced by the experimental set-up and its own detailed dosimetry. These
factors introduce limitations in reproducibility and are responsible for the
large reported variations in biological effects (Figure 1.3 - Sørensen et al. 2011
reviewed the reported RBE for different cell lines. In this figure the Chinese
Hamster Lung V-79 cell line was replotted as an example because of the high
number of available data). Desrosiers et al. (Desrosiers et al. 2013) associated
this lack of understanding with the unavailability (or poor availability) of
accurate dosimetry.
Figure 1.3. Plot of reported (Sørensen et al. 2011) RBE values for Chinese hamster
lung fibroblast V-79 cells irradiated with carbon ion beams. The variations seen
are probably due to biological variability and dosimetry uncertainties. Data
reproduced from Sorensen et al. with kind permission.
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1.3 Introduction to Radiobiology
1.3.1 Radiation Interaction with Cells
The main result of the interaction of ionising radiation with atoms and molecules
is the production of free radicals which is generated due to the energy absorp-
tion and breakage of chemical bonds. These free radicals are responsible for
some of the radiation effects on biological tissues and organisms. In addition
to being highly reactive, these radicals are found in a number of biological
processes, metabolism, oxidation, reduction, and pathological diseases and
cancer induction (IAEA 2010).
Radiation causes a wide range of DNA lesions (Figure 1.4) such as:
• Single strand breaks in the phosphodiester linkage;
• Double strand breaks on opposing sites or displaced;
• Base damage;
• Protein-DNA crosslinks and protein-protein crosslinks involving nuclear
proteins such as histones and non-histone proteins.
Although the number of DNA lesions generated by irradiation is large,
thanks to repair mechanisms only a smaller fraction of these lesions give rise
to cell inactivation/kill. Of the different types of cell damage, double strand
breaks (or DSB) have been recognised as important for cell killing and in regard
to the ability of cells to repair such lesions. Evidence has increasingly shown
the importance of complex DSB lesions after high LET irradiation (IAEA 2010;
Kraft et al. 1992; Zirkle 1954).
Cell death is achieved once cells lose their ability to divide and duplicate
following radiation. This loss of reproductivity can occur by (discussed by
Lauber et al. 2012 and described in Figure 1.5):
• Apoptosis - Apoptosis is one type of programmed cell death. It is
commonly considered to be the prevalent form of cell death underlying
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Figure 1.4. Different types of DNA damage by radiation.
daily tissue regeneration and renewal. Morphologically, it is characterized
by cellular shrinkage, chromatin condensation, nuclear fragmentation,
and membrane bleeding.
• Necrosis or necroptosis - In tumour cells of epithelial origin, which
reveal limited apoptosis induction in response to radiotherapy, radiation-
induced DNA damage has been reported to stimulate necroptosis. The
crucial events in this context include the hyperactivation of the DNA
repair enzyme and the subsequent and substantial depletion of intra-
cellular ATP levels. Necroptosis is characterized by the production of
reactive oxygen species, lipid peroxidation, swelling of organelles, rupture
of the plasma membrane, and release of intracellular contents. Apart from
necroptosis, ionizing radiation can trigger necrosis, an accidental, uncon-
trolled form of cell death as a consequence of excessive physico-chemical
stress. Moreover, secondary necrosis can occur when apoptotically dying
cells are not properly and timely engulfed by neighbouring cells or profes-
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sional phagocytes, respectively. In both cases the integrity of the plasma
membrane is lost and cellular contents, often in an oxidatively modified
and partially degraded form, leak into the surrounding tissue.
• Mitotic catastrophe - Mitotic catastrophe is a form of cell stress,
which occurs in the context of as a result of aberrant mitosis owing to
uncoordinated or improper entry into mitosis. It has been assigned to
be the major death mechanism in response to irradiation-induced DNA
damage of cells with defects in cell cycle checkpoints and impaired DNA
repair mechanisms.
• Induced senescence - Radiation-induced senescence is a condition of
permanent cell cycle arrest, which can be observed in cells, where DNA
damage is excessive and cell cycle checkpoints are still intact.
Figure 1.5. Different cell death modalities induced by ionizing radiation. (Lauber
et al. 2012)
Apart from the induced senescence, all the cell deaths described above result
in physical loss of the cell. Despite that, the result of these processes are not
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immediate and require different cell divisions before they occur, e.g. mitotic
catastrophe may not happen until several divisions have taken place (IAEA
2010).
Radiobiological Models In order to evaluate the different responses (or
sensitivities) of cell types, the accepted gold standard is the evaluation of the
cell’s retention of its reproductive integrity or mitotic intactness, i.e. its ability
of a cell to undergo cell divisions and produce a viable colony (IAEA 2010).
Survival curves are best shown as a semilog plot of survival against irra-
diation dose and the most common model used in order to represent this cell
survival is the linear-quadratic model (LQM). The rationale for such quantita-
tive method is the need to predict dose-response relationships. This is specially
important when predicting isoeffect relationships for alternate treatments. In
contrast to earlier methodologies, which were essentially empirical descriptions
of past clinical data, the LQM formalism has become the preferred tool largely
because it describes a mechanistically based model, with tumour control and
normal-tissue complications attributed specifically to cell killing. The rationale
here is that a formalism with a mechanistic underpinning is less likely to be
subject to catastrophic failure, as had occasionally happened with empirically
based models (Brenner et al. 1998).
The LQM assumes that lethal radiation damage is created either by a
consequence of a single ionisation event or as a consequence of two, separated,
sub-lethal event which combined create a lethal damage (Dale 2004). These
different types of lethal damages are represented in Figure 1.6 below.
LQM is obtained by fitting a second-order polynomial, with the constants
α and β describing the decline of survival (S) with increasing dose (D) (as seen
in Equation 1.4 below). An example of cell survival curve was shown in Figure
1.2, where cell survival curves for the RAT-1 rat prostate cancer cells were
irradiated with different doses and radiation types (in this example X-rays and
carbon ions).
CHAPTER 1. INTRODUCTION 21
Figure 1.6. Schematic showing the formation of radiation damage as a result of
double-strand breaks (DSBs) in the DNA. The DSBs may be created in a single
ionizing event (Type A damage) or by complementary interaction between two
separate ionising events (Type B damage). In each case, the base sequence on
both strands is disrupted and cell lethality results. With Type B lethality, it is
necessary for the second ionizing event to occur before the first has had time to
repair itself. It is also necessary for the two events to be located within a few
base pairs of each other (Dale 2004).
S = exp[−(αD + βD2)] (1.4)
The α and β are regarded as the radiosensitive parameters of certain cell line.
The LQM assumes that there are two components to cell killing, where the
linear parameter (α) is correlated to the number of DSB associated to a single
event and the quadratic parameter (β) to DSB originated from two separate
events.
1.3.2 Repair of Radiation-induced Damages
Most DNA damages are repaired and just some rare lesions fail to do so.
Specialised repair systems are capable to detect and repair damage to:
• Bases - base excision repair (BER)
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• SSB - single-strand break repair (SSBR), closely related to BER
• DSB - homologous recombination (HR) and non-homologous end-joining
(NHEJ)
DSB are considered to be the most lethal of the different damages induced
by radiation. If not repaired, or wrongly repaired, DSBs can lead to loss of
chromosomal material, cell death, mutations and chromosomal rearrangements
(Kogel and Joiner 2010; McKinnon 2009). Figure 1.7 describes the different
repair mechanisms.
Figure 1.7. Different DNA repair mechanisms. (McKinnon 2009)
Homologous recombination (HR) As suggested by the name, HR uses
homologous undamaged DNA (that with an identical sequence) as the template
to repair the DNA with the DSBs in it. By using DNA with the same sequence
as a basis for repair, the process is error free (Kogel and Joiner 2010; McKinnon
2009).
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Non-homologous end-joining (NHEJ) NHEJ joins two DNA DSB ends
together without requiring homologous DNA sequences. This is a faster process
than in comparison to HR but it comes at the cost of accuracy, including small
deletions or insertions often resulting at the repaired break site. Although this
can lead to mutations, it allows the cell to survive (Kogel and Joiner 2010;
McKinnon 2009).
Other repair mechanisms As previously discussed even though DSBs are
associated as being the most lethal lesion induced they are not the most common.
Base damage and SSBs far outweigh DSBs in number, being up to 50 times
more frequent (Kogel and Joiner 2010; McKinnon 2009).
Since base damage and SSBs can also occur without irradiation due to
normal metabolism, their repair pathways (BER and SSBR) have evolved and
are capable of repair much more efficiently and preserve the genome integrity.
In BER, most of the damaged bases in the DNA will be detected and removed
by specialised proteins. These proteins, in addition to enzymes, will cut out
the damaged bases leaving a nick, or SSB. Subsequent repair involves replacing
the damaged base only or using a long patch repair where up to 10 nucleotides
are cut out and replaced. Repair of SSB is similar, but since the damages
were induced by radiation, there is an extra end-processing step to prepare
the connection ends, mainly through the use of an enzyme. Short (base only)
or long patch repair can then follow, in the same manner as BER (Kogel and
Joiner 2010; McKinnon 2009).
1.4 Discussion and Conclusion
A major challenge in Hadron Therapy is to accurately predict RBE for clinical
scenarios, and to determine which are the best mathematical models to correlate
LET and dose with RBE (Fossati et al. 2012). A contradiction compared to
photon (or conventional) radiotherapy is that currently a 2% tolerance in dose
variation is used as a quality assurance limit for accurate delivery of the dose
CHAPTER 1. INTRODUCTION 24
(Miller et al. 2013), but the radiobiological uncertainties with protons and
carbon ions exceeds this value. Currently uncertainties on RBE are in the order
of 10-20% (Karger et al. 2010) with RBE varying clinically between 1.5-3.4 for
carbon (Tsujii and Kamada 2012).
For protons, the prescription method is currently simplified by the use of a
generic RBE value of 1.1 (Paganetti et al. 2002). Although experimental in
vitro and some more limited in vivo data have been used to obtain this RBE
value (RBE from 0.6 to 1.5 with average between 1.1 and 1.2), some concerns
exist about the data sets and dose ranges used, with reports of more side effects
than expected (Jones and Errington 2000). This results in large variations
in the delivered biological dose in the target volume. These variations have
the potential for increased risk of normal tissue damage (Tsujii and Kamada
2012). The large RBE variability has been reported as possible reason to why
despite the improved conformity no reduction of adverse events were observed
for brain tumours (Combs et al. 2013). This can be explained by the increased
biological effect over the last few millimetres of the particles’ path, especially
when within or close to a critical structure (Paganetti et al. 2002).
Carabe et al. 2013 investigated the use of the 1.1 factor in proton therapy
versus a varying RBE. The authors discussed that, while this constant factor
had been proven to be a good average representation across the SOBP, in order
to achieve improved accuracy biological effects variations must be considered.
The authors also mentioned that in order for patient treatments to use these
biological RBE modelling, more reliable radiobiological data would be needed
for different cancer cell types and normal tissues.
One of the main challenges of modelling RBE is limiting its approximations
and therefore associated uncertainties. Boehlen et al. 2012 evaluated a clinically
used model and its susceptibility to errors due to its uncertainties or precision
in the parameters used. In their work, the Local Effect Model (LEM) was used
and in a sensitivity study the variability of the parameters used by this model
were evaluated. They suggested that by accounting for biological uncertainties
in treatment plans the outcome of these therapy modalities could be improved.
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Another possible limitation to modelling RBE is that since mathematical
models are as good as the data the model is based on, and, as it will be
discussed in the next chapters, the current available data may have introduced
uncertainties. By developing new tools, these uncertainties could be avoided.
There is also a divergence of opinion between researchers and clinical
institutions as to which are the most suitable biological approaches. This can
be seen by the presence of a large number of proposed models (Jones 2015a;
Kraemer and Scholz 2000; Lomax et al. 2004; Carabe et al. 2013; Fossati et al.
2012).
Lastly, it is difficult to detect clinically the misestimations of RBE and
survival (Boehlen et al. 2012). Especially given that the treatment outcome
(including toxicity evaluation) of such precise treatment techniques can not
be single out to uncertainties in RBE without excluding other factors such as
physical limitations.
Therefore, in order to achieve the best possible clinical outcomes after
Hadron Therapy, a larger range of experiments using human cell lines, tissue
explants and in vivo experiments at clinically relevant doses must be performed
in order to account for the limitations of current radiobiological experiments.
In addition, it is important to recognise current set-up limitations so that
improvements can be made to RBE estimations. This thereby allows for better
evaluations of treatment doses for tumour control and better protection of
normal tissues from unintended over-dosage. This must be undertaken in
conditions that simulate actual treatments with variations in depth of targets,
LET and dose ranges etc. For example the evidence that proton RBE varies with
depth has been previously suggested (Britten et al. 2013) but more evaluations
are needed.
All proton and carbon ions irradiations in this thesis were performed using
the active scanning method. Some of the uncertainties described in my work
(read beam uniformity, irradiation length, etc) could have been avoided or
reduced by using the passive scanning method. However this method was not
used since it is not widely available in new treatment facilities which mainly
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rely on active beam scanning method. Furthermore, the variation in dose
rates between different irradiation methods in respect to biological response
(passive scanning 1Gy/second and active scanning up to 103Gy/second) was
not thought to be relevant, particularly since, even at higher dose rates (laser
driven accelerators - 109Gy/second), comparable biological responses have been
obtained (Bin et al. 2012) .
1.4.1 ENTERVISION
The work presented in this thesis was done as part of my fellowship in the
ENTERVISION project. ENTERVISION was a Marie Curie Initial Training
Network (Dosanjh et al. 2015) project that was established in response to the
clinical need for further research into online imaging and improvements into
clinical protocols.
I was part of the work-group focused on pre-clinical development and
simulation of imaging strategies for image-guided hadrontherapy. As a subgroup,
our main task was the development of clinical treatment protocols for cancer
radiation therapy, which required high quality information on the biological
effectiveness of radiation doses using a range of beam qualities. This is especially
true in terms of hadrontherapy (Boehlen et al. 2012). Therefore, verification
procedures and future clinical protocols, multiple cell irradiation experiments
must be performed at different dose points using a range of generic and patient
specific tumour cell lines so as to gain robust data, which would ultimately
aid biological dose model developments. Consequently, the development of
radiobiological tools was extremely important and would serve to quickly verify
the biological effects of complex dose distributions in homeomorphic phantoms,
along with measurements of physical dose.
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Chapter 2
Literature Review of
Radiobiological Approaches
2.1 Aim
Different approaches have been used in radiobiological experiments. This
chapter will discuss the challenges presented by these approaches and evaluate
how these different uncertainties affect the final result.
The aim of this chapter is to evaluate and understand the difficulties
presented by the current approaches in radiobiological experiments and use
this knowledge to design a more suitable tool. These learning outcomes will be
the basis of a new phantom design that aims to reduce these uncertainties and
improve the final reported result.
The capability of this design to improve current radiobiological experiments,
will be evaluated in the following chapters in respect of its dosimetric precision
(Chapter 4) and biological output (Chapter 5), without introducing extra
uncertainties in the final results (Chapter 3). Finally, Chapter 6 summarises
the results obtained from both capabilities of the phantom and draws conclusions
on their impact on RBE and the biological dose which is needed for Hadron
Therapy.
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2.2 Introduction
Despite its relatively long history and accumulated experience, radiobiology is
still considered to be very imprecise. A recent review (Desrosiers et al. 2013)
identifies dosimetry, or the lack of it, as the main concern for the reliability
of radiobiological experiments. This improvement in dosimetry is even more
important in the field of HT where uncertainties associated with the physical
and biological properties of the ion beam and modern delivery techniques are
challenges for the delivery of the correct dose (Carabe et al. 2012; Paganetti
2012).
A review was performed in order to understand the previously described
uncertainties for the different experimental approaches used in radiobiologi-
cal ion beam experiments with respect to their characteristics. This allowed
conclusions to be drawn regarding advantages and disadvantages of each ap-
proach. Once these conclusions had been drawn, the need for a new device
for radiobiological experiments was evaluated. An optimal phantom would be
able to reduce the different sources of uncertainties in order, and, by doing
so, it would be able to achieve improved reproducibility. The ideal phantom
would be able to host different detectors and would therefore be able to reduce
uncertainties related to dose reporting and would provide improved dosimetry.
It would also be able to reproduce clinical treatment settings in terms of dose
and LET distributions with depth.
2.3 Methods
In this chapter, a literature review of existing phantoms and set-up conditions
for radiobiological experiments and their statistical reporting was performed. It
was observed that uncertainties are related to both dosimetry (physical output)
and the statistics of the biological output. The review was divided into the
verification of:
• Dosimetry or physical output which can explain the large error bars re-
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lated to reported dose. At this point, the dose measurement accuracy,
or estimation, was evaluated through the reported uncertainties associ-
ated with the chosen detector and detector positioning limitations. The
limitations due to the positioning include some systematic errors due
to user variability, which can be reduced by the introduction of fixed
detector positions and room positioning tools, for example with the aid
of alignment lasers. For consistency, it was established that whenever a
detector was not used (or not reported) the uncertainty was associated
with the maximum acceptable uncertainty of 6% (Jaekel et al. 2001b),
when performing measurements in phantoms from calculated doses in
more complicated dose configurations.
• Biological output which includes the statistical uncertainties as docu-
mented by the error bars associated with the reported cell survival. Most
of the biological uncertainties are caused by variations in technical pa-
rameters (i.e. cell maintenance) when samples are processed in multiple
batches (known as batch the effect (Leek et al. 2010)). These uncertainties
can be minimised by improving the experimental design allowing for large
amount of samples to be processed in the same way and at the same
time. This remains a very challenging task especially when clinic-like
irradiation settings are needed. The unique design of the novel phantom
proposed here will help to reduce technical sources of variation for the
preparation of samples and to obtain high quality experimental data.
Close attention was also paid to how to produce the best statistical inter-
pretation of RBE from the combined dose and cell survival uncertainties.
2.4 Results
Within the literature, three approaches are used in the majority of radiobiology
experiments:
• Cell Culture Flasks or Multiwell Plates. This technique consists of
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placing either a cell culture flask or a multiwell plate perpendicular to
the beam direction. In addition, the effects of the irradiation at different
positions along the beam path can be assessed by using multiples of such
items(Figure 2.1).
Figure 2.1. Left - The variety of cell culture plates and flasks that can be used in
ion beam studies. The present phantom design uses the 12-wells plates. Right -
The most commonly used experimental set-up for cell irradiation, which features
a vertically mounted cell plate irradiated by a horizontal beam.
• Physical Phantoms Adapted to Biological Experiments. This technique
involves tools that were initially created to assess beam parameters (i.e.
absorbed dose, beam fluence, etc.), which can also accommodate cell
flasks or plates (Figure 2.2).
• In-house Biological Phantoms. This technique encompasses different in-
house solutions which best suit the patient treatment or specific scenarios
(e.g. study of different oxygenation levels) (Figure 2.3).
The majority of radiobiological experiments (Barazzuol et al. 2012; Combs
et al. 2012) use the first technique described above (cell culture flasks or
multiwell plates). The advantage of this approach is its simplicity since most
of the required tools are commercially available and are ready for use with very
little preparation. In contrast, however, a few uncertainties may appear in the
form of poor reliability and reproducibility effects, due to a lack of online beam
information Desrosiers et al. 2013 discussed how to address these problems
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Figure 2.2. Examples of the second described set-up for ion beam experiments,
with specifically designed dosimetry systems used for cellular irradiations. This
figure shows the experimental approach used by Bert et al (Bert et al. 2010) with
kind permission. In this set-up, the cell flasks are positioned in the marked red
square in the figure labelled target.
Figure 2.3. Example of the third described set-up, an in-house ion beam phantom
used in radiobiological experiments. This Figure shows the experimental approach
used by Elsaesser et al (Elsaesser et al. 2010) with kind permission. The cells are
positioned in these in-house made plastic slices. One of the limitation of these
set-ups is that re-sterilisation is required prior to further use of these plastic
slices, which does not allow for multiple irradiations on the same day.
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associated with poor dosimetric approaches, which undermine the reliability
and reproducibility of available results in the literature. They found that these
problems were associated with different techniques of measurement, reporting
of radiation dosimetry, and setup conditions for radiobiology research. They
also pointed out that dosimetry for research in radiobiology in published papers
is frequently inadequately described, which suggests that the dosimetry itself
may have been inadequate.
This can also be seen in the PIDE (Particle Irradiation Data Ensemble)
database (Friedrich et al. 2013), which compiles the results obtained from
several cell survival experiments with ion beam irradiation. In comparing these
data to the αx−ray and βx−ray (x-ray linear quadratic model radiosensitivity
parameters), variations were reported for Chinese hamster lung fibroblast V-79
cells ranging from 0.098 to 0.184 [Gy−1] for α x−ray , which may reflect the poor
reproducibility of this set-up. Some of these deviations can be explained by the
fact that different V-79 cell lines contain variations in chromosome number and
radiosensitivity. As discussed, these variations can be due to the unpredictable
nature of working with living organisms, but there are also other systematic
physical uncertainties at play. For example, limitations in positioning and
dosimetry cannot be ruled out, but could have been avoided with a more robust
system.
The second technique described above (Physical Phantoms Adapted to
Biological Experiments) covers the use of what were originally physics-designed
phantoms for quality assurance procedures (Bert et al. 2010; Arjomandy et al.
2010), which were adapted for radiobiology experiments. As an example of this
approach, Bert et al. (Bert et al. 2010) (Figure 2.2) studied the effect of moving
compensation techniques in cell survival. In contrast to the first approach,
this technique allows for precise dosimetric assessment. Despite this, these
approaches are generally more labour intensive in the preparation stages, which
contributes to the difficulty in transportation and inter-centre comparisons
(whenever both centres do not possess all tools). Another possible limitation is
that not all physical phantoms can be adapted to host cell cultures.
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The final technique described above (In-house Biological Phantoms) consists
of the development of in-house solutions for radiobiology phantoms. The positive
aspect of this approach is that it comes the closest to representing a patient
treatment, as the beam distribution and cell conditions tend to reproduce
different desired scenarios. General examples of this approach include the
head phantom proposed by C. Gübitz et al (Guebitz et al. 2007, Sep 20.)
and evaluated by Mitaroff et al. (Mitaroff et al. 1998) and the array of cell
plates described by Elsaesser et al. (Elsaesser et al. 2010) (Figure 2.3 top and
bottom, respectively). Another example is the work described by Tinganelli et
al. (Tinganelli et al. 2013) where they were able to study the different dose
responses at different oxygen concentrations.
On the designs used by Elsaesser et al. (Elsaesser et al. 2010) and Mitaroff
et al. (Mitaroff et al. 1998), since multiple positions are available, and therefore
multiple points along the beam are analysed, fewer irradiations would be
necessary in order to understand how radiosensitivity changes at different LET
and/or dose values. The orientation of the Mitaroff et al. (Mitaroff et al.
1998) phantom enabled the user to evaluate the effect of a mixed particle beam
(containing both the primary beam particle and all other fragment particles
produced from its interactions) in simulating the patient scenario. Another
disadvantage of all these phantoms is the fact that all surfaces (the ones which
enter in contact with the cell culture) must be sterilised prior to use which
leads to increased preparation steps and a lower throughput of experiments
per day, and could lead to increased uncertainties in the final biological results.
Therefore, as they have the ability to represent desired cellular conditions
for studying the radiation effects in cell and tissue cultures, these phantoms
introduce great complexity to experimental preparation and analysis. Moreover,
not all of these phantoms are optimised for detector placement and evaluated
for the disturbance in the cell compartments produced by these detectors.
By studying different commercial and in-house solutions available for dosi-
metric and/or biological phantoms it became clear that in order to achieve
the required project goal, more than one type of phantom would be required
CHAPTER 2. LITERATURE REVIEW 34
for improved dosimetry and biological readouts. The main characteristic we
pursued for the phantom was the ability to have both physical and biological
measurements in a device which is transportable and has lower complexity for
usage and analysis of results. We also designed the phantom with the aim of
performing multiple irradiations in the smallest amount of time in order to
reduce for possible biological differences (Leek et al. 2010). In addition to its
unique characteristics, the phantom design was inspired by some positive traits
observed in previously reviewed phantoms.
In summary, Tables 2.1 and 2.2 compare the dosimetric and biological
outputs for the reviewed set-up and describe the advantages and disadvantages
of each technique, respectively.
From these observed uncertainties we were able to evaluate which effects
these uncertainties have on the calculated RBE. The discussion of these can be
found below.
2.4.1 Implications of the Observed Uncertainties
The observed uncertainties were divided into dosimetric ones due to the limi-
tations of chosen detectors and statistical ones due to biological output. The
implications of the different levels of these uncertainties were evaluated.
1. Dosimetric Uncertainties
The dosimetric uncertainties were evaluated by observing the effect
of the different reported dose uncertainties. This was done by obtaining
different fitted curves at different levels of uncertainty. Using the data in
Figure 1.2, I was able to estimate these effects by calculating the original
fitted curves and their respective curves at different levels of uncertainty
(1.0, 5.0 and 10.0%), which can be seen in Figure 2.4. With that data, I
was able to evaluate the RBE variation. To estimate the survival curve
variability (shown as shaded regions), we fitted the same functional form
to the measurement points which were perturbed normally around the
mean. The errors were treated as being of either a systematic nature (the
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Table 2.1. Comparison between different commercial and in-house phantoms and
their usability
Physical Output Biological Output
(Uncertainties associated (Uncertainties related
with dose measurement to statistical limitations)
and positioning)
Criteria Relative Detector Uncertainty Number of dose response points
(for ions)
GafChromic films Up to 96 laterally, and not
Barazzuol et al. 2012 4.6-5.1 % limited to a certain number of
(Martišíková and Jäkel 2010) in depth as stack is possible
Nothing or non reported Up to 96 laterally, and not
Combs et al. 2012 6.0 % limited to a certain number of
(Molinelli et al. 2013) in depth as stack is possible
Ion chambers
Bert et al. 2010 3.0 - 3.4% 1
(Karger et al. 2010)
TLDs
Mitaroff et al. 1998 4% 587
(Hoffmann et al. 1999)
Nothing or non reported
Elsaesser et al. 2010 6.0 % 1 in xy 30 in depth
(Molinelli et al. 2013)
Ion chambers Up to 96
Proposed Phantom 3.0 - 3.4% (8 laterally and 12 in depth)
(Karger et al. 2010)
error in the dose is likely due to a wrong dosimeter) or , of a statistical
nature. For the systematic assumption, the maximum deviation was
used and for the statistical variation these maximal errors were used,
but, instead of using the same value for all dose points, uncertainties
were applied randomly (with normal distribution) with the mean at the
measurement and sampled 100,000 times.
The original RBE obtained at 10% survival (RBE10) was 2.81, and
when 1% of the reported dose was used the calculated RBE10 became 2.81
± 0.05 (1 standard deviation). For 5% and 10% uncertainties, I obtained
RBE10 values respectively of 2.81 ± 0.23 (8%) and 2.83 ± 0.46 (16%).
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Table 2.2. Advantages and disadvantages of compared phantoms and proposed
phantom.
Advantages Disadvantages
Cell Culture Flasks or Commercially available tools Dosimetric accuracy
Multiwell Plates allowing for multiple
(Barazzuol et al. 2012) irradiations
(Combs et al. 2012)
Quality Assurance
phantoms adapted to Highest dosimetric precision Low number of dose
biological experiments points increasing
(Bert et al. 2010) necessity for repetitions
(Arjomandy et al. 2010)
In-house Biological In-house cell tools; increased
Phantoms Possibility of emulating patient sterilisation uncertainties
(Elsaesser et al. 2010) irradiation conditions and fewer possibility of
(Mitaroff et al. 1998) re-irradiations
All of the above Limited number of dose
Proposed phantom points owing to commercially
available products
These results highlight the importance of reducing the levels of uncertainty
related to the reported dose, including detectors and positioning. Figure
2.4 represents the obtained fitted curves at different levels of uncertainty.
2. Biological Uncertainties
The biological uncertainties, as mentioned above, were mainly sta-
tistical due to the limited number of sampled points. Moreover, there
is no consensus on how to optimise the obtained results and correctly
report their confidence interval. The statistics of cell survival fraction
have been recently reviewed (Paganetti 2014) for protons. The statistical
uncertainties associated with the survival fraction as well as the data
fitting to provide the parameters α and β in the linear quadratic model
are understood well, but there is little guidance in the literature regarding
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Figure 2.4. Evaluation of the effect of different levels of uncertainty in the reported
dose on the fitted curves. The shaded area represents different levels of statistical
uncertainties in the dose measurement. The uncertainty for the different detectors
described in Table 2.1 are within these studied levels.
the calculation of RBE confidence limits. Based on Fieller’s theorem, the
proposal by Gupta et al. (Gupta et al. 1996) can be applied to RBE as
described in the biological experiment chapter, in Section 5.3.5. This
method allows for more precise calculations of RBE and its confidence
limits, taking full advantage of the optimised biophysics of the phantom.
Current Radiobiological Uncertainties
I then evaluated this approach with the data presented by Tinganelli et al.
(Tinganelli et al. 2013), since there are a limited number of papers that present
current radiobiological uncertainties and their confidence limits. The original
reported values were 0.136 ± 0.044 and 0.029 ± 0.004 for α and β x − rays,
respectively. For carbon ions the reported curve was fitted with a linear fit
instead of a linear quadratic. The reason for forcing the β to zero and using
a linear fit instead of a linear quadratic is owed to the fact that at certain
experimental data the obtained β factor can be negative if a linear quadratic
curve is fitted. The reported α for the carbon ions was 0.936± 0.056 and the
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RBE was 2.8± 0.2.
In Figure 2.5, the data from Figure 1.2 were re-plotted with the fitted curves
(y = exp(−αx−βx2)) with these reported values and with maximum deviations
(α + delta(α), β + delta(β), and α- delta(α), β- delta(β)). As mentioned above,
as per the reported values, y = exp(−x)) was used for the carbon ions data.
With these variations, the reported levels of uncertainties currently present in
the literature can be seen.
Figure 2.5. Plotted values from reported fitting parameters for RAT-1 rat prostate
cancer cells irradiation with carbon and x-rays. The dotted lines have been
used to represent the fitted curves with higher deviation and the shaded area
represents the variations. The blue curve is for x-rays and the green one for
carbon ions. Data from Tiganelli et al. (Tinganelli et al. 2013) used with kind
permission.
Proposed Statistical Approach
As proposed by Gupta et al (Gupta et al. 1996), the uncertainties of a ratio of
two quantities (C = A/B) can be expressed by Fiellerś Theorem:
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C +
(
g
1− g
)
∗ C
}
±
(
Z
B ∗ (1− g)
)
∗
√
(C2 ∗ VB) + VA ∗ (1− g)
where, g =
(
Z
B
2
∗ VB
) (2.1)
where VB and VA are the variances of B and A respectively and Z-score
allow us to describe the confidence interval (CI) in terms of probability value.
With this theorem I was able to derive the uncertainty of the final calculated
RBE value (Equation 2.4) by calculating its confidence interval (Section 5.4.2).
The uncertainty of every measured survival at different dose points was
calculated as described in Section 5.3.2. Then the survival curve could be
obtained by fitting these to a linear quadratic equation, in order to describe the
cell survival at different dose points. The RBE10 (Equation 1.3) is a ratio that
relates the dose to obtain a isoeffect (in my case, the 10% survival) between a
radiation test and a reference radiation and is easily obtained from the fitted
curves.
The Maximum Likelihood Estimation (MLE) optimisation was used in order
to obtain the optimised fitting curve. It works by maximising the agreement
between the calculated survival points and fitted curve and thereby reducing
the uncertainties associated with the values obtained from the fitted curve
(Dorfman and Alf Jr 1969). The likelihood function is defined by (equation
2.2):
L(θ : x1, ..., xn) =
n∑
i=1
f (xi|θ) (2.2)
Since optimisers in statistical packages typically minimise a function, it is
possible to mathematically modify this equation. As the logarithm function is
a monotonic function, optimising the logarithm of the function is the same as
optimising the function itself. And using available optimisers (Science Python
Statistic Library Minimise Function (Jones et al. 2001)) and minimising the
CHAPTER 2. LITERATURE REVIEW 40
negative log-likelihood is equivalent to maximising the log-likelihood or the
likelihood itself (Equation 2.3).
L(θ : x1, ..., xn) = lnL(θ : x1, ..., xn)
lnL(θ : x1, ..., xn) = −
n∑
i=1
ln f (xi|θ)
(2.3)
Once the uncertainties associated with the fitted curves are known (in
this example Vx−ray and Vcarbon), the Equation 1.3, and therefore the 95%
RBE Confidence Interval (CIRBE), can be expressed in terms of the obtained
parameters.
RBE10 =
Dx−ray
Dcarbon
95%CIRBE =
{
RBE10 +
(
g
1− g
)
∗RBE10
}
±
(
1.96
Dcarbon ∗ (1− g)
)
∗
√
(RBE210 ∗ Vcarbon) + Vx−ray ∗ (1− g)
where, g =
(
1.96
Dcarbon
2
∗ Vcarbon
)
(2.4)
This method was used in order to obtain the new optimised α and β
parameters and RBE confidence interval. From these new parameters and their
uncertainties (Table 2.3), Figure 2.5 was re-plotted as described above in order
to evaluate the effect of different uncertainties on the survival curves.
Table 2.3. Before and after optimised fitting of radiobiological results.
Parameters Reported After optimisation
X-rays α 0.136± 0.044 0.166± 0.021
β 0.029± 0.004 0.026± 0.003
Carbon Ions α 0.936± 0.056 0.954± 0.028
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Figure 2.6. From these new optimised parameters and their uncertainties (Table
2.3), Figure 2.5 was re-plotted as described above in order to evaluate the effect of
different uncertainties in the survival curves. The darker shaded area represents
the optimised values and the lighter area represents the original values for fitted
curves its variations. The blue curve is for x-rays and the green one for carbon
ions. Data from Tiganelli et al. (Tinganelli et al. 2013) used with kind permission.
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From the optimised fitted curves, the RBE10 value was calculated. Fiellerś
theorem was applied and the RBE 95% confidence interval was calculated
(RBE10 = 2.76 with 95% CIRBE = 2.53, 3.02). The reduced uncertainty in the
fitting, due to the optimisation, can be directly observed from the difference
between the shaded areas in Figures 2.5 and 2.6. The variation of the RBE can
be expressed in terms of the reduction of uncertainties of the fitting parameters.
When the RBE was calculated for the obtained parameter uncertainties the
RBE varied between 2.32 (-17.1%) to 3.42 (+21.7%) compared to the reported
2.81. With the optimised parameters the RBE obtained was 2.76 varying from
2.51 (-9.1%) to 3.11 (+12.6%). This demonstrates the possibility of reducing
uncertainties in RBE estimation and reporting by using an optimisation method.
2.5 Evidence for a New Design
The new design, shown in Figure 2.7, is a dosimetry tool aimed at inter-facility
comparisons, for verification of the delivered dose and radiobiological effects at
different positions (and thereby also the beam quality) of a given plan. This
particular phantom set-up would allow us to verify different radiobiological
models that link LET to bio-effect in conditions where the dose is constant
but LET is variable, as is the case in different positions along the SOBP. The
phantom could also be used for beam profiling and treatment plan verification.
The phantom offers two options: the first concentrates on the physical prop-
erties of the delivered beam and the second on delivering biological response
information.
By using the described methods, multiple irradiations can be performed at
the same beam time and on the same day. This will facilitate high-throughput
data acquisition from biological samples prepared in the desired experimental
setting. Also, with a formal statistical method accounting for the improved
physical and biological estimations and an optimisation fitting method, a
more accurate RBE and its confidence limits can be reported with reduced
uncertainty.
CHAPTER 2. LITERATURE REVIEW 43
Top view of Phantom
Technical Drawings of  
Phantom Design (dimensions in mm)
Front views at the two first detector depths
Figure 2.7. Technical drawings of the designed biological dosimetric Phantom. The
different detector positions available and the cell holders can also be seen for
the first two depths. In this design, the cell holder plates are then positioned
along the beam axis covered by SOBP with the beam entry at the front of the
phantom. All the reported dimensions are in mm.
2.5.1 Design
The proposed phantom, shown in Figure 2.7, consists of a PMMA block with
dimensions of 240.0 ± 0.1 x 240.0 ± 0.1 x 146.0 ± 0.1 mm (in HWL), machined
to accommodate a standard multi-well cell holder, for cell irradiations, and
ionisation chamber pinpoint detectors at different positions. PMMA was
chosen as it has similar properties to water (Yajima et al. 2009; Brusasco
et al. 2000), to enable an easy dose to water conversion to be performed (see
Material Selection Section 3.2.3). Dosimetric water equivalence is evaluated
by uniformity of effective densities for relevant interactions and is essential to
energy degrading of ion beams for range shifting, range compensation, and
dosimetry (Kanematsu et al. 2013). An insert, from the same phantom material,
was made for the commercial 12 multiwell plates used in this thesis in order
to reduce uncertainties in the range calculation due to the air gaps present.
Additional visual description of the phantom can be found in the Appendix A.
The design enables on-line information about the requested SOBP to be
obtained from the available detector positions at the same time as cell cultures
are irradiated. The phantom offers two options for experimental set-up:
• The first concentrating on a radiobiology experiment, which consists of a
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laterally uniform dose distribution, enabling the user to obtain several
irradiation points (the number of irradiation samples is limited by the
type of multi-well cell holder used) for different depths without the need
to repeat the irradiation; and
• The second concentrating on evaluating a complex dose distribution. This
can provide a biological dose assessment with respect to lateral and depth
distribution and the absorbed dose.
By measuring the dose deposition at the different known detector positions,
an improved dosimetry at the cell holders location is obtained. Thus, by using
a dose distribution calculation (for example by using Monte Carlo simulation as
described in the coming chapter), it is possible to obtain the dose distribution in
the different locations of the phantom, including the known detector positions.
This makes it possible to verify the accuracy of the delivery plan, to benchmark
the calculated dose distribution and a chosen resolution, and therefore to rely
on the dose in different positions according to the obtained calculation.
2.5.2 Detectors
Radiation detectors are extremely important in all radiotherapy modalities,
and hadrontherapy is no exception. Detectors permit the measurement of the
absorbed dose, allowing control of the beam delivery and quality. Ionisation
chambers were selected as the main detectors due to their widespread use
in reference dosimetry by all major national and international bodies (IAEA
2000) and due to their common use as the main detectors in quality assurance
procedures (Karger et al. 1999; Molinelli et al. 2013). Although ionisation
chambers were chosen as the main detectors, alanine detectors and radiochromic
films could also be considered appropriate for both dosimetric purposes and/or
beam quality assessment (Herrmann et al. 2011; Spielberger et al. 2002). Table
2.1 describes the estimated uncertainties for different types of detectors used
by radiobiological experiments, these uncertainties are associated with dose
measurement and positioning. Table 2.4 provides an overview of the advantages
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of the chosen detectors for this project. A complete table with several possible
detectors can be found in the literature (Karger et al. 2010).
Table 2.4. Proposed detector types for this phantom including their advantages,
disadvantages, and clinical applications. (Karger et al. 2010)
Detector Type Advantage Disadvantage Application
Ionisation Chamber
High accuracy
and
reproducibility,
small LET and
energy
dependence,
easy to handle,
many chamber
types for
different
applications
Corrections for
deviation from
calibration
conditions
required,
incomplete
knowledge of
corrections
(chamber
dependent)
Reference
dosimetry,
commissioning,
dosimetric QA,
dose
verification,
beam
monitoring
Films
High spatial
resolution, 2D
measurement
LET and
energy
dependence,
dose cannot be
obtained from
optical density
in mixed fields,
off-line analysis
required
Measurement
of lateral dose
profiles, beam
widths, field
geometry and
homogeneity,
documentation
of beam ports
Alanine
Nearly water-
equivalent,
linear response
LET and
energy
dependence,
off-line
evaluation with
electron spin
resonance
Point
measurements
2.5.3 Criteria of Radiobiology Phantom
The ideal phantom is able to obtain dose response during cell irradiation,
this allows for improved dosimetric accuracy and better correlation between
biological response and irradiation profile.
The criteria for the phantom were:
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• Dosimetric accuracy - which depends on the uncertainty associated to the
detector type used. For this thesis, ionisation chambers were used, and
as described in Table 2.1 their uncertainty is 3-4% (Karger et al. 2010).
This choice was due to their low uncertainty for ion beam irradiations
and their availability clinically. In Section 2.4.1-1, the effects of detectors
uncertainties were evaluated for RBE estimation. Figure 2.4 demonstrates
these detector uncertainties in the fitted curves.
• Biological uncertainties - which can be divided into the capability to
perform multiple irradiations in order to produce the statistical variation,
and the ability to correlate cell survival to the physical dose. For this
thesis, the 12 multi well plate was used, but the phantom is capable of
holding up to the 96 multi well plate (Table 2.1).
And by obtaining dose response during cell irradiation, it is possible to
study cell survival by multivariate physical quantities (for example LET and
Dose).
2.5.4 Justification of Criteria of Phantom Design
Section 2.4.1 discussed the implications of these dosimetric uncertainties in the
final RBE estimation, where 5% and 10% uncertainties translated into 8% and
16% uncertainties in the RBE, respectively. As has been described (Section 1.4)
most radiobiological experiments either use detectors which have uncertainties
in this range or adopt dose calculation uncertainties within this range (Table
2.1).
The biological uncertainties, which translates into the clinical level of RBE
uncertainty and therefore patient biological dose, also need to be taken into
account particularly when they lay within the order of 10-15 % (for protons and
higher for carbon ions) (Paganetti et al. 2002; Tsujii and Kamada 2012). This
is one of the main negatives aspects associated to the hadrontherapy (Jaekel
et al. 2013) as the treatment outcome is defined by the biological dose that is
obtained by the multiplication of the RBE with the physical dose. Therefore
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in order to maximise hadrontherapy treatment capabilities, efforts need to be
made to keep these uncertainties to a minimum (Boehlen et al. 2012; Carabe
et al. 2013; Carabe et al. 2012).
2.6 Conclusion
In order to improve our knowledge of enhanced radiobiological effectiveness,
which is necessary to support clinical proton and ion beam applications, more
dedicated tools need to be developed. In cases where observed disadvantages
with some experimental set-ups (Table 2.1 and 2.2) can be reduced, a phantom
with dosimetric information about the delivered beam would allow radiobiologi-
cal experiments to gain the necessary reliability and reproducibility (Desrosiers
et al. 2013). I have introduced a new design with the potential to reduce uncer-
tainties in reported dose and biological effect associated with the experimental
set-up. The phantom was designed to accommodate different types of detectors,
which will reduce the uncertainties related to dose reporting (more than 50%
if taking into account the reduction in uncertainties by using a more precise
detector) and reproducibility. It also allows the investigations of the biological
response and in relation to both dose and LET in the same manner as in clinical
treatments. By using commercially available tools to host the cell cultures, the
phantom permits several irradiations to be performed with the minimum intro-
duction of biological deviations (same cell preparation, use of sterile tools, etc.).
In addition, a statistical approach based on Fieller’s Theorem was described in
order to improve the confidence interval in reported RBE. It was shown that by
the use of such techniques, a further reduction in RBE uncertainties is possible.
The results from the phantom testing are described in the following chapters for
the phantom’s dosimetric and biological characteristics and its overall ability
to reduce statistical uncertainties at different hospital facilities with different
ion beams. The presented approach of a formal statistical method, which takes
into account the improved physical and biological estimations, will provide a
more accurate RBE and its confidence limits.
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Chapter 3
Phantom Modelling and Design
Evaluation in Monte Carlo
Simulations
3.1 Aim
In the previous chapter, the evidence for a new phantom was presented, and
from that a new design was introduced. The aim of this chapter is to study
the implications of the chosen design and steps taken into account in order to
reduce the possible uncertainties introduced and, by doing so, benchmark the
computational tools developed.
The phantom aims to provide a radiobiological tool for studying biological
dose delivery along with the ability to obtain improved dosimetric information
from the delivered beam. This tool would be used to assess the biological
response from different beam distribution configurations, allowing optimisation
and biological verification of the treatment dose calculations and performance
comparison of different Treatment Planning System (TPS) and Dose Delivery
Systems (DDS) at different centres.
The work presented in this chapter was performed by using MC simulations.
In order to verify the results and the accuracy obtained by those simulations,
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benchmarking was performed with experimental data. Moreover, this study
aims to understand the trends and uncertainties of the chosen phantom geometry
and design with respect to improving its final dosimetric accuracy. The following
sections present the methods employed to study these limitations, the expected
performance based on MC simulations, and a discussion of potential effects of
any found limitations on the results obtained in radiobiological experiments.
3.2 Introduction
The main areas of concern regarding the development of the phantom were
the uncertainties associated with the radiobiological experiments including
biological uncertainties and dosimetric accuracy (Section 2.5.3), and the un-
certainties introduced by the chosen phantom design. After introducing the
design, the main concern was to understand the effects of the chosen materials
and detectors on the introduction of uncertainties.
Firstly, the range of uncertainties in the dose calculation due to the chosen
phantom material was evaluated (Section 3.2.3). Subsequently the effect of
the chosen detector positions was investigated. For this step, we evaluated
whether the ionisation chambers placed at the chosen positions suffered from
chamber-chamber effects (Section 3.4.3). We defined the chamber-chamber
effect as the interference suffered by ionisation chambers, or any chosen detector,
due to the interaction of the particle beam with the neighbouring ionisation
chambers. This effect has previously been investigated (Parcerisa 2012) for
carbon beams, but since protons are more susceptible to beam perturbation, for
example beam widening due to scattering, I saw a need for further investigation.
We also evaluated the effect of possible disturbance on the dose distribution in
the central region where the cell culture to be studied was located, which would
have been introduced by the inhomogeneities of the chosen detector (Section
3.4.3). All these evaluations were done with MC simulations.
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3.2.1 Monte Carlo Simulations
MC simulations have been used for different applications in medical physics for
several years (Rogers 2006). This use is even more intense in areas which are
directly affected by radiotherapy dosimetry calculations, for example treatment
planning dose calculations, dose verification for complex treatment techniques,
radiation detector response calculations, image reconstruction and correction,
and so on (Verhaegen and Seuntjens 2003). Although MC simulation is consid-
ered the gold standard in dose calculation, in the clinical environment it is not
yet possible to benefit fully from this superiority since MC simulations are still
considered too time consuming. Several approaches have been attempted to
improve this, from the use of graphical processing units (or GPUs) (Giantsoudi
et al. 2015) to the use of approximation steps (Fix et al. 2013), but for clinical
scenarios, pencil beam algorithms, which are considered to offer a reasonable
compromise between accuracy and computational speed for treatment planning,
are still employed.
For HT, this is even more challenging as not the pencil beam algorithm
needs to account for not only the primary, but also all the secondary products
of the interaction of the primary beam particles and the medium. Kraemer et
al. (Kraemer et al. 2000) proposed a pencil beam model for treatment planning
which can be used to calculate the dose generated by a single heavy ion beam
with Ebeam:
D(Ebeam, x)[Gy] = (1.6x10−8)d(Ebeam, z)
 MeV
g/cm−2
 N
2piρ2[mm2]exp(−
1
2
r2
ρ2
).
(3.1)
where r is the distance from the beam centre, ρ is the width of the Gaussian
beam profile, and N is the total number of particles. Most importantly,
d(Ebeam,z) describes the energy loss as a function of penetration depth, z,
taking into account contributions from all different particle species, T , with
their given energy spectra, which are the products of projectile fragmentation.
CHAPTER 3. PHANTOM MODELLING 51
d(Ebeam, z) =
∑
T
∫
E
dE
dN
dE
(Ebeam, z, T, E)
dE
ρdx
(T,E) (3.2)
As the applied beam model which calculates the deposited dose uses water
or water-equivalent material as a reference, the concept of Water Equivalent
Path Length (WEPL) was introduced in order to account for density variations
on the beam path. Then the TPS is able to interpret the CT information and
convert the obtained Hounsfield units (HU) into WEPL by the creation of a
look-up table where high-density or low-density voxels are translated into a
modified path factor that is shorter or longer, respectively, than the one used
if water is present. So once a correlation between HU and WEPL has been
created, a translation grid between the original CT voxels’ positions and the
WEPL corrected positions is created. The advantage of this approach is that
it is possible to apply any models developed for water. Figure 3.1 shows the
representation of this path modification and the experimental data used to
create an example of a fitting to interpolate between different materials (Jaekel
et al. 2001a), but as shown by He et al. 2012, this fitting is CT scanner specific
and the use of a general approach can lead to deviations larger than 10 mm.
Figure 3.1. Left - Conversion between imaged information and WEPL. Right -
And the proposed HU-to-WEPL conversion with the PMMA value marked.
These algorithms need some physical quantities that are computed with MC
codes, such as the depth-dose distribution, beam widening and fragmentation
production in water for different ions. For instance, MC simulations have
been used to compute the input parameters of the TPS that is in clinical
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use for both protons and carbon ions since the start of patient treatment
in November 2009 in Heidelberg Ion Beam Therapy Center (HIT) (Parodi
et al. 2012). Besides for beam characterisation of the TPS, MC simulations
can be used to validate some dose calculations, especially in cases with great
tissue heterogeneities (Mairani et al. 2013), to accurately analyse the dose
delivered to patients and the calculation of biological effects (see Chapter
5). Additional areas of MC simulation applications for Hadron Therapy are
support for risk-estimation for secondary cancer induction, radioprotection,
and aiding developments for monitoring tools. For example, estimation of
the production of β+ emitters, such as 11C and 15O, important for Positron
Emission Tomography (PET) imaging and the production of prompt photons
produced by the nuclear interactions (Boehlen et al. 2014).
FLUKA Monte Carlo Code
FLUktuierende KAskade or Fluctuating Cascade (FLUKA) is a multi-purpose
MC transport code originally designed for high-energy physics but with exten-
sive use in medical applications. FLUKA is intrinsically an analogue code,
but it can be run in biased mode for a variety of deep penetration applica-
tions. For all MC simulations within this thesis FLUKA, (Boehlen et al.
2014; Ferrari et al. 2005) was the Monte Carlo code chosen for this project
due to its demonstrated capabilities (physical and biological dose calculations,
range verifications, setting up of different libraries necessary for the treatment
plan commissioning, etc...) in HT (Mairani et al. 2010; Mairani et al. 2013;
Parodi et al. 2012) and its powerful graphical tools (Vlachoudis 2009). All
geometry simulation, updates and modifications were completed with the aid
of FLAIR (a graphics user interface of FLUKA). There are currently two ways
of describing the geometry within FLUKA: either by using a combinatorial
boolean approach (Emmett 1975), and/or by the use of voxels, a possibility
that allows detailed tridimensional representations and interconnection with
medical imaging modalities like Computed Tomography (CT), PET and so
on. This feature is particularly useful for dosimetry or treatment planning
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purposes.
For the purpose of this thesis, the HADROTHErapy suite of physical
settings (known as defaults) was selected. This suite handles the selection of
the appropriate electromagnetic physics parameters (EMF package) related to
the transport of electrons, positrons, and photons; inelastic factor corrections
to Compton scattering and Compton profiles; particles transport threshold;
multiple scattering threshold for both primary and secondary charged particles
and δ-ray production.
For all hadrons except neutrons, the transport threshold, that is, the energy
below which particles are deposited uniformly over the residual path, was set
to 100 keV as suggested (cf. FLUKA manual). Neutrons are slowed down to
thermal energies. To reduce computing time without compromising accurate
energy deposition calculations, the electrons/positrons and photons transport
thresholds, that is, the levels below which energy is deposited locally, were set
to 30 keV and 3 keV, respectively. The effect of these different thresholds (delta-
ray productions and transport, electromagnetic and neutron processes etc.)
have been previously extensively evaluated and benchmarked for the selected
geometries. The main part of the geometry description is the description of
the beam line, and the part of the MC code representing both beam lines used
have been evaluated and good agreement was obtained as such that the MC
simulations aid on the treatment plan acceptance at both HIT and Centro
Nazionale di Adroterapia Oncologica (CNAO) (Mairani et al. 2010; Mairani
et al. 2013; Parodi et al. 2012).
Limitations of Monte Carlo Simulations
Monte Carlo simulation is the use of randomized numerical experiments to
evaluate mathematical expressions. The main advantages are its simplicity
since extensive knowledge is not required when using complete packages in
order to obtain a solution. The MC simulations should be used with care due
to several limiting factors. First, MC simulations values are only as good as
the description of the geometry adopted in the simulations (Lima et al. 2016).
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This also influences the estimation of error. The probabilistic error, which is
essentially based on the variance, may not be a good measure of the simulation
precision. This explains the need to benchmark against measurements. The
second limitation relates to the required time to perform these simulations. MC
simulations are slow as many samples are required in order to obtain acceptable
precision. This is due to the fact that probabilistic error decreases as the
reciprocal square root of the number of iterations.The third limitation concerns
the uncertainty of the interaction modelling. On the whole, the physics is not
exactly known, so MC can only be useful in making predictions if someone is
using the code to actually look and compare the simulation of specific scenarios
to data. These errors are systematic errors; they are separate from the variance
and are not quantified by the variance. Systematic errors can only be evaluated
from comparison with experiments and/or from knowledge of the uncertainties
of each model.
3.2.2 Details about the Set-up of the Monte Carlo Sim-
ulation
In this section we will introduce the different terms and steps associated with
FLUKA simulations used in this thesis.
The MC simulations are divided into two parts: beam description and
irradiation target. Each of these parts needs to be validated individually.
The beam description represents the description of the irradiation profiles
(calculated by the TPS) and geometrical description of structures that may
affect this irradiation profile until the target. The irradiation target, is the
geometrical representation of the desired target to be irradiated. In this thesis
the target is the phantom. The beam description depends on which facility the
test has been conducted at.
Beam Description CNAO is a synchrotron accelerated hadrontherapy facil-
ity clinically delivering both protons and carbon beam treatments. A complete
detailed description of CNAO facility current clinical capabilities are further
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described in Section 4.3.3 (Rossi 2011; Molinelli et al. 2013). In order to cor-
rectly simulate the dose deposition, it is necessary to account for the different
structures present in the beam path during the description of the geometry.
These structures are the vacuum window, the monitor units and the ridge
filter (only for the carbon irradiations). Below, Figure 3.2 and 3.3 show the
schematics of the accelerator and treatment rooms, and the dose delivery sys-
tem including the structures present. Figure 3.5 shows the same dose delivery
system description in a three-dimensional model generated for the FLUKA
simulations.
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Table 3. Planning of the phase I tasks.
Fig. 8. Underground floor layout of CNAO complex, showing the accelerators and the treatment rooms.
Starting from the 15th month, all three halls will be operational and used for the treatment of patients also with
carbon ions. In parallel, the follow-up of rats irradiated with carbon ions will be continued for the assessment of late
CNS toxicity.
The timeplan has been approved and started in October 2010. As initially planned the dosimetry and radiobiology
tests with protons in Room 1 have been completed in July 2011 and soon patients treatment will start in parallel with
carbon ion tests in Room 3.
3.2 Request for authorisation to experimental treatments
The second step towards the completion of the clinical trial at CNAO is represented by the definition of clinical
treatment protocols with protons and carbon ions ([9] and references therein). CNAO doctors have defined a set of
Figure 3.2. The CNAO accelerator design, including its pathway to the 3 treatment
rooms are included in the schematics of the synchrotron design (Rossi 2011).
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Figure 3.3. The CNAO delivery system can be seen in these figures showing a
photograph of the system (top) and a model with description of its components
(bottom) (Rossi 2011).
The validation of this DDS geometry generated with FLUKA has been
described previously (Molinelli et al. 2013), but for the particularities of the work
done in this thesis it needed to be re-evaluated. Initially, MC simulation were
validated against experimental results (Figure 3.4), after which the calculated
depth dose curves were implemented in the TPS database.
Physical parameters used in the TPS either derive directly from MC or
were tested with the simulations. Therefore, the MC-based verification tool was
identified as a benchmark for the evaluation of TPS analytical dose calculation
accuracy. As discussed by the authors (Molinelli et al. 2013), the main difference
between the MC and and the TPS is in respect to the lateral dose distribution
modelling (Figure 3.4b). This is mainly due to the oversimplification of physical
interaction processes applied in the TPS by the use of double Gaussian in
comparison to detailing description of multiple scattering processes used in the
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Dosimetric accuracy of a treatment plan verification system for scanned proton therapy 3845
(a) (b)
Figure 2. (a) MC calculated depth-dose-distributions in water (lines) are depicted together with
experimental data (points) for nine different beam energies. The experimental data have been
normalized to the MC values. (b) MC calculated FWHM at the isocenter of the beam line as a
function of the proton beam energy. The solid lines refer to the calculated FWHM LIBC for the
focus so far configured. The points with the error bars represent the experimental data.
Figure 3. For each data set exceeding the warning level the mean absolute deviation is plotted.
Measurements are compared to four different scenarios of calculated values: • TPS calculated
dose; N MC simulated dose based on treatment plan data; ! MC simulated dose based on DDS
log-files; ♦MC simulated dose based on DDS log-files and corrected for the optimal 3D holder
shift. For the last case, the applied translation vector, expressed in mm, is also reported between
brackets.
in the TPS dose calculation model. The average over nine data sets of mean absolute deviations
of the experimental data compared to TPS and MC calculations decreased from 4.2% ± 0.8%
to 3.5% ± 1.1%, respectively, but still major single point deviations (> ± 7%) were present.
The same plans were then recalculated using the MC tool on the basis of the treatment
log files generated by the DDS to investigate uncertainties related to the dose delivery process.
The average over 9 data set of mean absolute deviations further decreased to 2.4% ± 0.7%
and the number of cases above the warning level reduced to 1, while single point deviations
still ranged between ± 7%. When the experimental set-up uncertainty was also accounted for,
Figure 3.4. (a) MC calculated depth-dose-distributions for nine different beam
energies in water (lines) are depicted together with experimental data (points).
(b) MC calculated beam resolution at the isocenter of the beam line as a function
of the proton beam energy. The solid lines refer to the calculated FWHM LIBC
for the focus so far configured. The points with the error bars represent the
experimental data. Figure obtained from authors with kind permission (Molinelli
et al. 2013).
MC code.
FLUKA Geom trical r presentation of 
CNAO beam line. 
accelerator nozzle water phantom
Figure 3.5. The generated FLUKA representation of the CNAO dos delivery
system can be seen in this figure. The accelerator nozzle can be seen, which
corresponds to the last structures in the DDS and also the water phantom used
for quality assurance.
In addition to the DDS description, the FLUKA default user routine (which
functions as a series of personalised computation scripts) was adapted in order
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to be able to correctly interpret irradiation plan files into the simulations. In
FLUKA , a built-in function called "source.f" must be used in order to obtain
different irradiation descriptions (orientation, starting location and particle
fluence). Users are able to personalise this function for their individual case. At
a typical ion beam irradiation plan, the beam is divided into varying, multiple
starting locations and particle numbers per location.
The modifications applied to the original source code can be found in
Appendix B. The main changes was the interpretation of irradiation plan
information into FLUKA variables:
• Location variables: XFLK, Y FLK, ZFLK,
• Kinetics energy variable: TKFLK, and
• Number of particles to be simulated: PARTICLESUM.
The code was initially provided by the Medical Physics team from CNAO,
but, due to the clinical use of CNAO simulations, the version of FLUKA
and the one used in my simulations were different. In order to make the code
work in my FLUKA version I had to update the links and imported variables
present in this user routine. Furthermore, I had to correct the simulation
reference to match the TPS orientation as the irradiation plan are generated in
this reference orientation. At CNAO and other centres, this re-orientation is
currently done during the post-processing stages.
3.2.3 Validation of Irradiation Target - Material selec-
tion
Polymethyl Methacrylate (PMMA) was the chosen material for the phantom
due to its wide use in hadrontherapy (Yajima et al. 2009; Brusasco et al. 2000)
and its composition comprising elements with low atomic numbers, homogeneity
and cost compared to other water-equivalent materials (Kanematsu et al. 2013).
One possible issue when selecting the material for a phantom is understand-
ing how this choice can affect the proposed experimental set-ups. As previously
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stated, the phantom is to be used as a tool for complex dose distribution
verification and radiobiological experiments. In both scenarios, the delivered
dose distribution is obtained by analytical calculation from the TPS, and the
presence of different material densities could impact on the dose distribution
due to the introduction range of uncertainties during calculation (Paganetti
2012).
The main contributor to this uncertainty is the difference in stopping
powers between materials and how the dose calculation software recognises
these differences. Figure 3.6 below shows the difference in stopping powers
between these materials. This plot was obtained from the tabulated values
produced by SRIM (Ziegler et al. 2010).
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Figure 3.6. The plots at the top display the tabulated data for electronic stopping
power at different energies for both water and PMMA and for carbon ions and
protons respectively. The plots at the bottom represent the calculated deviation
between the two materials. Data obtained from the tabulated values produced
by SRIM (Ziegler et al. 2010).
Another possible limitation, as described by Jaekel et al. 2001a, is that
although PMMA is measured, it is normally excluded from the clinical fittings
for HU/WEPL conversion (compared with Figure 3.1) owing to its non-tissue
equivalent composition. Thus, in order to correctly account for the dose
distribution with the TPS, the WEPL of the PMMA had to be measured
(Kraemer et al. 2000; He et al. 2012; Brusasco et al. 2000) and correctly applied
in the dose calculation. In this section, I also evaluated the effect on the correct
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material description in the MC simulation.
3.2.4 Influence of Detector Positions in Dose Measure-
ments and Dose Distribution in the Cell Compart-
ment
With respect to the detectors, the uncertainties associated with their dosimet-
ric capabilities and their implication for the final radiobiological experiment
results have been covered in the previous chapter, but the implications of the
chosen positions for a possible beam disturbance due to the presence of non-
homogeneities on the beam path need to be evaluated. The main assumption
is that since the distance between each detector and between detector and
cell compartment is not inferior to the distances used by current commercial
dosimetrical tools, no disturbance will be detected.
While the aforementioned dosimetrical tool was initially design for carbon
beams, proton beams are more susceptible to scattering, which could present a
issue that has not been previously evaluated.
3.3 Methods
3.3.1 Validation of Phantom Modelling
The benchmarking of the MC simulations was divided into two steps. The
first was the evaluation of the mean dose deviation between a uniform dose
distribution and ionisation measurements, followed by the same evaluation
with different non-uniform dose distributions. Once the beam description was
validated, the second step was to evaluate the irradiation target by comparing
the measured and calculated depth dose profiles and estimating the WEPL.
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Validation of Beam Description
As part of the Quality Assurance (QA) tests in HT facilities, cubes of known
dimensions are irradiated. In this thesis irradiation experiments were carried
out following the evaluation of a uniformly distributed dose (in the shape of a
cube) centred at 9 cm depth in water with dimensions of 6 x 6 x 6 cm. The
experimentally obtained ionisation chamber measurements were compared with
the calculated dose depositions from the TPS and MC.
For the purpose of benchmarking a non-uniform dose distribution, previously
published data were re-analysed (Molinelli et al. 2013). In this, the authors
investigated nine patient plans where the warning QA threshold (fixed at 3%
mean dose deviation between measurements and TPS) was crossed. The data
consisted of ionisation measurements, MC simulation and TPS dose deposition
calculations.
The authors originally explored the possibility that these differences found
were related to:
• Dose modelling (TPS vs MC),
• Limitations of the dose delivery system, or
• Incorrect positioning of detectors.
Other factors, such as the oversimplification of dose modelling were not ruled
out. One reason for analysing their data was the availability of experimental
measurements using, the CNAO dose delivering system for benchmarking my
MC simulations. Moreover, they had used similar detector distances for their
phantom in relation to my proposed phantom. Other reasons included the
amount of availability of data (both experimental and dose calculations), and
the fact that, instead of using the full 24 positions available in the ionisation-
chamber holder (see Figure 3.7), they had only used 12. (see Section 3.3.2 for
further details).
The current CNAO quality assurance procedure (Ciocca et al. 2012; Molinelli
et al. 2013) specifies that a verification will be performed for each patient plan
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(Karger et al. 1999). In order to do so, a water tank with a 3D detector block
controlled by a motorised arm (PTW-Freiburg GmbH) is used. This allows
the dose deposited at different known depths and positions to be measured.
This detector block is a holder for the ionisation chambers (PTW pin point
chamber which have a 0.03 cm3 sensitive volume), in a such way that the
ionisation chambers do not obstruct the direct path of the beam. According to
the QA procedures, PTW-Freiburg GmbH pinpoint ionisation chambers were
used. (Figure 3.7). The measurement values for each ionisation chamber is
then compared with those values calculated by the TPS (Equation 4.2). For
data set analysis, the mean deviation is calculated as the difference between the
measured (dmeas,i) and the calculated dose (dcalc,i), normalized to the maximum
beam dose (dmax) and averaged over N IC positions i:
1
N
N∑
i
|dmeas,i − dcalc,i|
dmax
% (3.3)
The number of points N included in the calculation can be equal to or lower
than 12, depending on the dataset. The TPS provides a 3D-averaged dose
gradient for each IC position. Points with a calculated gradient higher than
0.04 Gy mm−1 are excluded from the analysis, since they can not be measured
accurately enough owing to the finite size of the detector sensitive volume
and experimental set-up uncertainties. For QA measurements in reference
conditions, as recommended by the International Commission on Radiological
Units (ICRU), the applied acceptance threshold is 5% for both mean deviation
and standard deviation over a data set. This approach is taken in order to
guarantee that delivery of the dose to the planning target volume in the patient
is within an uncertainty of less than 5% at the 2ρ level (ICRU Report 24 1976).
Current MC patient plan verifications, as per the TPS, use a simpler
approach to geometrically represent the ionisation chambers when calculating
the dose deposition. None of the detectors’ structures and holders are included
in the geometrical description, and the detector dose is sampled from the dose
distribution in a water tank. By so doing, the structure and materials of the
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ionisation chambers are not taken in consideration for the simulation. But
differently from the TPS which uses only one voxel value, MC obtains the
deposited dose in the chambers by calculating the average dose to water over
several voxels, corresponding to the active volume of the detector, situated in
the positions where the chambers would be located.
N∑
i
(dcalc,i − dmeas,i)2
∆di
(3.4)
where ∆di is the 3D dose gradient in the IC position i over the N IC
positions in the data set.
The aforementioned approach, with its geometric approximations and sim-
plifications, was found to obtain the correct results for the majority of studied
cases. But, for the example of the nine cases where the agreement between the
MC simulations and measurements was found to be unsatisfactory, we decided
to investigate the impact using detailed geometry in order to account for the
dose disturbances, mainly from scattered particles produced in the wall of the
ionisation chambers and detector holder.
In the new detailed geometry, all of the geometry described above is kept,
including the PTW3D block and ionisation chamber description (with respect
to all structures, dimensions, and material compositions). Detailed technical
drawings were obtained from the manufacturer (PTW Freiburg). The FLAIR
geometry editor was instrumental and extremely helpful in dealing with drawing
and 3D visualisation (Figure 3.7). As for the original MC approach, the final
deposited dose is the contribution of the different voxels present on the active
volume of the detector (Equation 3.4).
For the purpose of this part of the work, the ionisation chamber measure-
ments were compared with the MC simulation results for the current set-up
with 12 chambers. These results were used to benchmark our simulations
and we were then able to compare the effect of introducing the remaining 12
ionisation chambers (Section 3.4.1).
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Validation of Irradiation Target
The depth-dose profile of a 270 MeV/u 12C beam was measured with a water
absorber. The tool used was the Peakfinder, by PTW-Freiburg GmbH, a
water column system for peak detection in protons and ion therapy. It is a
closed water column which is able to measure BP positions with a relative
spatial resolution of 10µm up to 35 cm depth. It contains a built-in thin
window ion chamber and it is read out by a electrometer. The software package
included allows precise measurements and a detailed Bragg peak analysis. The
measurement of the BP is made with and without the material in which the
WEPL (Equation 3.5) needs to be calculated. In my case a PMMA slab from
the phantom was placed along the beam path, with 20mm thickness.
WEPLi =
(rwo − rw)
ti
(3.5)
where WEPL for a material i is obtained by the subtraction of the rwo,
range in water without the presence of the material, by the rw , the new range
with the introduction of the material in the beam path, divided by the thickness
of the material, ti. The range is the position of the measured bragg peak in
water.
For the purpose of benchmarking our calculated WEPL results and simula-
tions, the phantom was tested for both protons and carbon ions at CNAO and
the effect of correctly accounting for the WEPL was analysed by comparing
the different dose depositions.
Additionally, the material description used by FLUKA simulation is evalu-
ated. During the simulation the material description was done by the "MATE-
RIAL" and "COMPOUND" cards (as it is called in FLUKA). The different
entries present in the initialisation file. As definition, these cards describe a
single-element material or a compound. Steps were taken to evaluate whether
the default description was able to correctly describe the dose deposition and
range. For the PMMA material, the default description (composition, atomic
number, etc.) was evaluated by estimating the effect of the default density of
CHAPTER 3. PHANTOM MODELLING 65
1.20 g/cm3 in the dose deposition.
3.3.2 Design Evaluation
Once the beam description had been validated the phantom design was evalu-
ated.
Detector Positions - The Chamber-Chamber Effect
To study the chamber-chamber effect, the available data (ionisation dose
measurement points) obtained with the phantom developed by GSI (Karger
et al. 1999) and commercialised by PTW-Freiburg GmbH were used (Figure
3.7). The primary reason for this choice was that the distances adopted by
our phantom design were similar to those used by this commercial phantom.
Another reason for using this phantom was the amount of available experimental
data, for both protons and carbon beams, as this is the phantom of choice in
both hadrontherapy facilities using different ions in Europe (HIT and CNAO).
Figure 3.7. Graphic representation from MC simulation and real pin point ionisation
holder array from PTW-Freiburg GmbH.
To study the chamber-chamber effect the same approach as was used to
benchmark the simulation was selected. At CNAO, the measurements were
made with half of the proposed number of the detectors (24), so data from MC
simulations were compared with two different set-ups, one with all 24 ionisation
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chambers versus the same set-up with 12. The difference between the two
simulations was then evaluated. A comparison was subsequently made on the
dose difference between these 12 (or 11) measurements per patient for a total
of 10 patient treatment plans.
Dose Distribution Disturbance in the Cell Region
Once we had decided to proceed with the proposed design and the detector
positions, the worst possible disturbance that the detectors could introduce to
the dose distribution in the central region was studied.
Figure 3.8. Graphic representation from MC simulation of the phantom and
uniformity study for dose disturbance evaluation. It includes a frontal view (top
left), from above (top right), lateral view (bottom left) and a 3 dimensional view,
all of them showing the 1Gy uniform dose deposited in a cube centred at 9 cm
depth with 6x6x6 cm dimensions. On the top right image can also be seen the
location of the SOBP centre and position of the calculated profiles.
As previously discussed, the phantom is able to accommodate different types
of detectors, so I decided to replace the ionisation chambers in our simulations
by tungsten cylinders in order to increase the effect of beam disruption due to
the presence of a high value Z and high density material in the beam path. All
other specifications including materials and dimensions were kept the same. We
CHAPTER 3. PHANTOM MODELLING 67
simulated a uniform SOBP centred at 9cm deep, corresponding to the centre
of the phantom, with dimension of 6x6x6 cm as shown on Figure 3.8. From
the recorded dose grid, profiles were taken perpendicular to the central axis at
different depths (at the centre of the SOBP ±2cm) for simulation both with
and without detectors. The doses differences were then calculated.
3.4 Results
3.4.1 Validation of Phantom Modelling
Benchmarking of Beam Description
Firstly, in order to benchmark our simulation, the MC simulations were com-
pared with the measurements for a simpler irradiation geometry with less
dependence on the detector positioning. As previously explained, the dose
deposition obtained by a uniform cube was evaluated. Figure 3.9 below shows
the isodoses calculated by the TPS and the calculated dose values at each
ionisation chamber position.
Figure 3.10 shows the comparison between the measured values and simu-
lated results and the obtained deviations. On the top plot, blue points represent
the ionisation chamber measurements and associated errors (set at 3% as pre-
viously described), and red points represent the introduced simulation, with its
obtained uncertainties. On the lower plot, I calculated the deviation between
MC and measurements and the shaded area represents the error associated
with the ionisation chambers.
A mean deviation of -0.142% was obtained with a maximum of 2.8%,
minimum of -1.8% and standard deviation of 1.7%. This shows how much my
simulation agrees with the measurement. These mean deviations and maximum
deviations are within the detector uncertainties therefore it may be possible to
accept the simulated geometry of the dose delivery system for the continuation
of the thesis. Although before continuing, since these values are within the
uncertainties of the MC simulation, it was necessary to further investigate the
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Figure 3.9. TPS representation of the isodose and ionisation chamber dose from
the uniform cube irradiation. Image obtained from CNAO, with thanks to the
medical physics team.
capabilities of MC dose calculation for less uniform irradiation fields.
Furthermore, as previously discussed, the mean deviation from nine different
patient plans were evaluated and compared with respect to my simulations.
Measurement points were obtained during the plan verification in addition to
the calculated doses from the TPS. The plot below (Figure 3.11) represents
the obtained results.
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Figure 3.10. Calculated Dose Deposition and Deviations between Measurement and
MC. On the top plot, blue points represent the ionisation chamber measurements
and associated errors (set at 3% as previously described), and red points represent
the introduced simulation, with its obtained uncertainties. On the lower plot,
the calculated deviation between MC and measurements is shown, the shaded
area represents the error associated with the ionisation chambers.
Figure 3.11. Calculated deviations between measurements, TPS (filled circles),
original MC (triangles) and introduced MC simulation with improved geometrtic
description of ionisation chambers and holder (red crosses).
When comparing deviations from the different dose calculations (TPS or
MC) the one produced with the detailed geometry gave the closest agreement
with the measurements, obtaining a mean of 1.90% versus 4.19% and 2.36%
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from the TPS and other MC simulation, respectively. The other statistics
obtained can be found in Table 3.1 below.
Table 3.1. Statistical analysis obtained from the different dose calculation
methods.
Relative Deviation from Measurements
Values in (%) Mean Maximum Minimum Standard Deviation
TPS 4.19 5.93 3.55 0.75
Introduced MC 1.90 3.07 1.00 0.63
Original MC 2.36 3.68 1.28 0.75
In order to evaluate whether the differences between the original MC
simulation and the MC simulation with detailed geometry are statistically
different a student t-test was used. From this test, a sigma value of 0.048 was
calculated, confirming the statistical difference of the obtained results.
3.4.2 Validation of Irradiation Target
Initially I measured the WEPL with respect to the selected material. The
average ratio of the WEPL to the geometrical thickness of the phantom plates
was 1.19 ± 0.02, compared to the value of 1.17 ± 0.011 obtained by Krämer
et al. (Kraemer and Scholz 2000), and since the PMMA materials vary in
composition and density between different vendors, it is somewhat expected
that different results will be obtained for the WEPL. The measurements in
Figure 3.12 left were performed using the same sampling. Variations between
the curves with and without PMMA are due solely to the difference in edge
sharpness.
Table 3.2. Range measurements obtained for WEPL measurements with Peakfinder.
All in mm 90% Proximal 90% Distal 50% Distal 10% Distal Peak
Pure Peak 150.08 150.84 151.28 151.99 150.54
PMMA 126.21 126.96 127.42 128.48 126.67
Difference 23.87 23.88 23.86 23.51 23.87
Table 3.2 shows the difference obtained between the Bragg peak with
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and without the presence of the PMMA. This information is also seen in
Figure 3.12 in the left. Once these rages were obtained, the WEPL value
was calculated. This WEPL was then introduced to the dose calculation, and
for benchmarking purposes the effect of the dose calculation with the correct
PMMA conversion was plotted (in this case FLUKA Monte Carlo simulations
was used for comparison), and compared with the general PMMA description
obtained by the dose calculation software. Regarding the correction with
respect to the material, the measured doses corresponded to the calculated
dose deposition (Figure 3.12). The results presented in this plot will be further
described in the following chapter where the experimental set-up and results
will be discussed.
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Figure 3.12. Left: Peak position measurements with and without PMMA slab.
Right: SOBP before and after WEPL correction compared to experimental results
Moreover, I evaluated the material description of PMMA in respect to
its density. Figure 3.12 shows that when using the default values, problems
are evident in the beam range. In order to improve this simulation result,
modifications were made to the material density. By default PMMA is described
by having a density equal to 1.20 g/cm3 but in literature it is possible to find
reported densities between 1.21 to 1.17 g/cm3. Figure 3.13 shows the variation
obtained by these different densities.
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Figure 3.13. The effect of different PMMA densities in the FLUKA simulations in
respect to the obtained measurements. The choice was made to use the value of
1.18 g/cm3 for all simulations of the designed phantom. Y-axis represents the
normalised dose and x-axis the detector position. The difference between one
detector and the next is 1.00± 0.01cm
The x-axis in this plot is the ionisation chamber position. The difference
between one detector and the next is 1.00±0.01cm. The difference between the
different simulation can be mostly noted in detector position 9, where the range
description can be evaluated. It can be seen, that with the chosen value of 1.18
g/cm3 for the PMMA density, the simulation describes well the measurements.
For all simulations of the proposed phantom, this value was used.
3.4.3 Design Evaluation
The effect of the chosen detector position was evaluated. First of all, the
Chamber-Chamber effect was evaluated followed by the evaluation of the dose
deposition in the cell compartment.
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Chamber-Chamber Effect
Table 3.3. Calculated deviations between 24 and 12 chambers with respect
to measurements.
Relative Deviation from Measurements
Values in (%) Mean Maximum Minimum Standard Deviation
TPS 4.19 5.93 3.55 0.75
Introduced MC 1.90 3.07 1.00 0.63
24 Detectors 2.00 3.29 1.18 0.70
Since this modified simulation obtained comparable results to the measurements
(Table 3.1), a new simulation was then performed with all 24 chambers and
the results obtained were compared (as shown in Table 3.3). The comparison
was made from the 12 (or 11) ionisation chambers present in both simulations
for each of the 10 patient treatment plans. A two-tailed t-test was performed
and no significant difference (sig. 0.76) was found between the two simulations
with 12 or 24 chambers. Figure 3.14 shows the calculated deviations for each
dose point for the different data sets for both MC simulations. This shows that
at the used distance, disturbance will not be cause by detector to neighbouring
detectors.
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Figure 3.14. Calculated deviations between MC dose calculations with 12 and 24
ionisation chambers. The blue dots represent the calculated relative deviation
between different ionisation chambers dose deposition for both configurations
with 12 and 24 chambers. The red line represents the mean of these measurements
and the right plot represents the histogram of these deviations.
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Dose Distribution Disturbance in the Cell Region
Figure 3.15 shows the deviations obtained from the introduction of a high value
of Z and high density material in the beam path, mimicking the effect in which
the dose distribution would suffer from the presence of non-water equivalent
detectors.
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Figure 3.15. The dose difference was obtained from three profiles along the x-axis
for different depths the first at the start of the SOBP at z=7cm, the second in
the middle of the SOBP at z=9cm and the last at the end with z=11cm. The red
area represents the location of the cell compartment and the grey area represents
the 95% confidence interval.
The dose difference was obtained from three profiles along the x-axis for
different depths the first at the start of the SOBP at z=7cm, the second in the
middle of the SOBP at z=9 cm and the last at the end with z=11cm. The red
area represents the location of the cell compartment and the grey area represents
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the 95% confidence interval. No difference was observed as the deviation for
most of the points are within the uncertainties of the measurements. This
shows that for the central region where the cell compartment is located the
presence of the detector will not introduce any non-uniformities in the dose
deposition. This is important for the biological experiments where uncertainties
in the dose deposition and range must be reduced or avoided.
3.5 Discussion
In this chapter, the limitations of the chosen phantom design were analysed.
Firstly, the MC simulations had to be evaluated since they were used for all
the further steps in the design evaluation. With respect to benchmarking of
the MC simulations, for the simplistic scenarios where the dose distribution
was relatively easy, that is, where there was a uniform dose distribution, it
was observed that the calculated deviations were within the MC uncertainties
of 2.91 % and within 2.76% (Figure 3.10). Whenever a non-uniform dose
distribution occurred, it can be seen from Figure 3.11 that improving the
geometrical description of the simulation represents an improved agreement
with the measurements in comparison with not only the TPS but also the
current MC approach used clinically. Therefore after these modifications to
the geometry description, a good agreement was obtained.
Once the MC simulations were validated, I was able to show that no
significant difference was observed between the simulations with 12 versus 24
ionisation chambers (Figure 3.14). Since the chosen distance in the proposed
phantom was similar to the ones used in this commercial phantom, it was
confirmed that these positions would not interfere with the future measurements.
This allowed the current design to be tested for possible disturbances in the
central region where the cell culture would be placed.
Lastly, I evaluated the dose deposition in the cell compartment. The MC
analysis (Figure 3.15) showed that most of the points, in the desired region,
were within the confidence interval of 95%, which demonstrated that there was
CHAPTER 3. PHANTOM MODELLING 76
no significant difference in the delivered dose with the use of the detectors.
Few points fell outside of this confidence interval. Those which did can be
explained by statistical fluctuation or poor uniformity of the original beam
profile. Despite these few points outside the confidence interval, the results
could be seen as satisfactory as all points lay within 1.0% of the original, which
corresponds well with dosimetry requirements.
The only possible limitation was the chosen phantom material, but, as
demonstrated above this limitation can be overcome by accounting for the
material WEPL during the calculation of the irradiation plans (Figure 3.12),
as has been discussed in the literature (Jaekel et al. 2001a).
In Chapter 2, I introduced the phantom criteria needed to obtain more a
reliable radiobiological results. The criteria were divided into:
• Dosimetric uncertainties; and
• Biological uncertainties.
Dosimetric uncertainties refer to the limitations arising from the different
set-ups and chosen detectors. Biological uncertainties in this thesis are related
to biological limitations that can be overcome. For example, the use of sterilised
commercial tools for cell plating and multiple irradiations at same conditions
to avoid batch effects. In contrast to errors associated with intrinsic biological
limitations cannot be overcome. For example plating efficiency that is both
cell and surface type dependent.
3.5.1 Dosimetric Uncertainties
Dosimetric uncertainties will affect the results in two possible ways, either be
not being able to correctly evaluate the dose profile or by disturbing the beam
which will irradiate the cells. In both cases, wrongly dose reporting diminishes
the biological results.
In relation to the different set-ups described in the previous chapter, some
groups (Combs et al. 2012; Elsaesser et al. 2010) either do not report their
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dosimetric methods or do not perform dosimetry and by doing so rely on the
capabilities of the delivery systems. A recent clinical review on patient plan
verification (Molinelli et al. 2013) showed that 86% of irradiation plans were
within clinical limits of ± 3% mean deviation between calculated and measured
doses. For the cases where the results were above these limits a re-calculation
of the plans with the dose delivery beam information showed that the mean
deviation, in the worst cases reduced from 5% to 2.5%, but in general an
average 1.5% reduction in the mean deviation was obtained. This was due
to mechanical limitations when delivering the different beam positions that
differed by a few mm between the irradiation plan and delivered beam which
demonstrates a source of limitation with these devices. As for the proposed
phantom, these limitations would be noted during irradiation and the correct
dose profiles could be calculated, thereby allowing for correct reporting of dose
delivered to cell compartment.
Other groups use set-ups that are also capable of evaluating the beam
delivery (Bert et al. 2010; Mitaroff et al. 1998; Barazzuol et al. 2012), but
different to the proposed design, the implications, by the introduction of these
detectors, have not been assessed specially in respect of the inter-detector
interference and dose deposition disturbance in the cell compartment.
Clinically each individual ionisation chamber is calibrated by a standard
laboratory for absolute dosimetry and the used of multiple, near by, chambers
were evaluated. I found that the mean deviation between sets of data containing
half of the detectors provided the same results as sets of data with the full set
of detectors (mean deviation of 1.90 versus 2.00 % respectively for incomplete
and complete set of detectors in the measurements). This demonstrate that
the detector measurements with the proposed phantom were free from any
disturbance arising from the adjacent detectors (no significant difference was
found, calculated two-tailed student t-test sig. 0.76). This gives confidence
in the measured values allowing for a, comparison with the MC simulations.
These distances are also used by other groups, but had not been previously
tested (Bert et al. 2010).
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In addition, by aligning the detectors outside the beam path to the cell
compartment area, the results of the phantom showed that the cell irradiation
region was free from introduced disturbances since I was able to demonstrate
that the hypothesis which proposes that there is no variation when introducing
chambers found to be valid at a confidence level of 95% for 95.3% of the
evaluation points. Other groups (Mitaroff et al. 1998; Barazzuol et al. 2012) use
different detectors (films or TLDs) in the beam path of the cell compartment
which can influence the dose profile by the presence of different WEPL. No
evaluation for these uncertainties in the dose distribution have been performed.
In Figure 3.15, the areas outside of the red shaded area show that deviations
up to ± 2% can be introduced by the introduction of detectors in the beam
path.
3.5.2 Biological Uncertainties
The limitations concerning biological output are directly linked to the reported
dose. By the reduction of dosimetric uncertainties the reliability in radiobio-
logical results is improved. In addition to this, as mentioned previously this
phantom was built in order to use commercially available cell plating tools
which allows for multiple irradiations with cells produced at the same time
(this is evaluated in Chapter 5) and reduce uncertainties in sterilisation.
3.6 Conclusion
In this chapter, I evaluated some aspects of the phantom design and the
computational tools which are used in the next chapters. The main attribute of
the phantom is its superior dosimetry output. As described in previous chapters,
the majority of radiobiology experiments either have limited or non-existent
dosimetric information.
The results contained in this chapter encourage the use of dose distributions
obtained by the MC simulation. This gives the possibility of using the MC
calculated dose distribution in the cell compartment region by evaluating indi-
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vidual irradiation plans and comparing the obtained ionisation measurements
to the MC dose distribution at the detector positions. The possibility of using
these dose grids calculated by the MC enables the evaluation of cell survival by
multiple physical and biological variables with a uncertainty at the level of the
uncertainty of the detector used.
The work in this chapter demonstrates that the chosen detector positions
would not disturb the dose distribution in the cell compartment and, therefore,
would not introduce uncertainties in the experimental results. Moreover, it
proves that it is possible to trust in the translation of the ionisation measure-
ments into the dose information at the cell compartment region since a good
agreement was obtained between the dose grid calculation by the MC and the
ionisation measurements.
Furthermore, the results presented in this chapter demonstrate the superior
dosimetric output that is obtained by this phantom in respect to other set-ups
either by correctly describing the dose profile (limitations on dose delivering
systems found in 14% of irradiation beams with errors up to 2.5% in the dose
delivery) or by not introducing extra uncertainties in the beam path (calculated
around 2% deviation by the introduction of detectors in the beam path).
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Chapter 4
Dosimetric Measurements of
Hadron Beams
4.1 Aim
The aim of this chapter is to verify the irradiation plan at different stages by
analysing the dosimetric output of the phantom, and I will demonstrate that
with the proposed design the calculated dose distribution can be correlated
with the measured dose points within 3% (relative uncertainty of the ionisation
chamber). And that the dose calculation for the whole target area of the
phantom can be validated in order to correctly report the irradiation dose of
the cell compartment. The calculated dose distribution in the whole phantom
could be obtained and the cell response in the cell compartment could be
correlated to the calculated dose distribution.
4.2 Introduction
The proposed phantom is capable of using commercially available tools for cell
culture which enables multiple irradiations to take place and provides for an
online response from the delivered irradiation, allowing for higher dosimetric
precision, additionally to simulating patient irradiation conditions.
In this chapter, the data from several experiments will be presented and
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analysed. As previously described, with the aid of the phantom the user is
able to monitor the absorbed dose during radiobiological experiments allowing
for an initial verification if the irradiation conditions were met. This allows
for, any mispositioning to be identified and corrected prior to proceeding with
the cell analysis, which is more labour intensive and time consuming. This
assessment of delivered dose also helps to verify different systems’ capability of
delivering the planned dose.
4.3 Methods
The phantom dosimetry has been determined from four different irradiations, at
two different facilities, varying the beam parameters to match different target
geometries within the phantom. Before describing each experiment in detail,
common features to all of experiments are outlined.
4.3.1 Multi-Centre Evaluations
Dose modelling and detector measurements were compared for the different
experiments so as to evaluate the accuracy of dose modelling for each irradiation
and facility. For all experiments, the physical dose or absorbed dose to water
in Grays [Gy] was measured at different detector positions using ionisation
chambers. Irradiations were performed with carbon-ion and proton beams,
except the first experiment at HIT where only carbon ion beams were used.
The goal was to benchmark the different dose modelling in respect to the
detector measurements in order to validate the dose calculation in the cell
compartment region.
4.3.2 Facilities
These irradiations were performed at CNAO and HIT facilities. At that time,
they were the only facilities in Europe which were clinically treating patients
with both proton and carbon ion beams and were widely recognised for their
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expertise in ion beam treatments.
CNAO
The Italian National Center for Oncological Hadron Therapy (CNAO) is a
hospital-based hadrontherapy facility equipped with a custom synchrotron and
dose delivery system (DDS) which provides actively scanned proton beams
with energies of 62–227 MeV/u and carbon ion beams of 115–400 MeV/u,
corresponding to ranges in water of 3-32 cm and 3-27 cm for protons and
carbon ions, respectively (Rossi 2011).
HIT
The HIT facility is connected to the neighbouring buildings of all clinical
departments of the University Hospital on the Campus of Heidelberg. A library
of pencil beams variable in energy, focus and intensity and ion species ranging
from protons to oxygen are provided by a linac-synchrotron combination with
a diameter of 20 m. The maximum energy for clinical applications is 221 MeV
for protons and 430 MeV/u for carbon ions. The range resolution in water is 1
mm for proximal depth and 1.5 for distal depth. The beam width ranges from
4-15 mm and the dose homogeneity is in the order of ±5% in over 80% of the
treatment field (Combs et al. 2010).
4.3.3 General Specifications
The phantom followed the individual facility procedure for patient irradiation
(Molinelli et al. 2013) from imaging, planning and quality assurance. Spot
scanning technique was used and a uniform dose (either absorbed [Gy] or
RBE-weighted [GyE]) distribution was chosen. These irradiations plans were
then used as input for the MC simulations, where RBE-weighted dose is the
product of the absorbed dose and the relative biological effectiveness (RBE)
factor. In the case of proton plans, a RBE-factor of 1.1 was used and for
carbons the factor was calculated with the LEM-I model (Kraemer and Scholz
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2000; Kraemer et al. 2000) by the TPS.
In all experiments the phantom was fitted with 22 PMMA mock ionisation
chambers placed in the detector holder positions and it was scanned with
a typical scan protocol used in clinic for cranial treatments. The position
of the phantom in respect to the irradiation isocenter was manually defined
during the CT imaging and recorded with fiducial markers, so that the selected
set-up could be easily reproduced in the treatment room. The use of treatment
motorised tables and laser positioning systems reduced positioning uncertainty
between planning stages and irradiations. After the scan the images were
transferred to the treatment planning system.
Using the CT images (1 mm3 voxel size) a 3D model of the phantom and the
predefined target volume was defined. The irradiation plan aimed to provide a
homogeneous coverage of the target volume with different physical doses by
one single horizontal field. The expected physical mean dose for each detector
was recorded and the plans were approved and sent to the irradiation room.
All treatment planning steps were performed by the CE-marked syngo® RT
Planning by Siemens AG Healthcare (Erlangen, Germany) version VB10, which
is based at the TRiP98 (Kraemer and Scholz 2000; Kraemer et al. 2000).
After the plan calculation, the irradiation took place. The data set in all
measurements consisted of the simultaneous use of 24 (when available) ICs
(PTW model 31015), connected by two multi-channel precision electrometers
(PTW Multidos). A graphical description of the phantom and beam orientation
is found in Appendix A.
Since cell survival had also been evaluated (see Chapter 5 for more details)
for the experiments performed at HIT, the decision was taken to irradiate
the phantom with a uniform absorbed dose instead of the biological dose
approach that was used for the CNAO experiment. This was done in order
to reduce any possible sources of uncertainties included in the biological dose
calculation model as discussed in the literature (Boehlen et al. 2012). One
example used from the literature included the method in which the RBE-factor
is calculated according to different input parameters, related not only to the
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physical properties of the used beam, but also the target cell line. This method
would also be applicable for my experiment since the cell line inputs currently
available differed from the one used.
At these experiments performed at HIT were also obtained both dosimetric
and biologic measurements. The biological output of the phantom including
the description of the different experimental set-up for these experiments are
described and discussed in the Chapter 5.
Dosimetry
Ionisation chambers (PTW-Freiburg GmbH Pinpoint chamber Type 31015)
connected to PTW-Freiburg GmbH Multidos Webline electrometer were cali-
brated in terms of absorbed dose to water. Each irradiation was measured and
converted to physical dose according to TRS-398 (IAEA 2000) and described
by the equation 4.1 below:
Dw,Q = MQND,w,Q0kQ,Q0 , (4.1)
where MQ is the reading of the dosimeter taking into account the product
Πki of correction factors for influence quantities (i.e. temperature, pressure
and recombination corrections), ND,w,Q0 is the calibration factor in terms of
absorbed dose to water at a reference quality Q0, and kQ,Q0 corrects for the
difference between the reference beam quality Q0 and the actual quality Q
being used.
During HIT experiments, 24 ionisation chambers were used in contrast to
CNAO experiments where only 12 ionisation chambers were available at the
time of testing. These pin-point ionisation chambers have vented sensitive
volume of 0.03 cm3 (which requires air density correction) with inner diameter
of 2.9 mm, the wall material is graphite with a build-up cap made of PMMA
and aluminium anode.
During some of the irradiations, the phantom was also irradiated with the
presence of radiochromic EBT3films (ISP) before the cell compartment to check
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the homogeneity of 2D dose distributions for scanning beams. The main focus
of the measurement was not an absolute dosimetric evaluation of the profiles,
which would demand further extensive studies, but rather an evaluation of the
homogeneity of the optical densities.
Monte Carlo Simulations
As previously discussed in Section 3.2.1, FLUKA is the MC code chosen for
dose simulations. As result of these simulations, a dose deposition in water is
calculated in a 3-D grid of 1mm3 voxel size. This voxel size is chosen to be the
same dimensions of the CT imaging size.
Data Analysis
Pursuant to the quality assurance procedures of both CNAO and HIT (Molinelli
et al. 2013) each ionisation chamber measurement values were compared with
those values calculated by the Monte Carlo simulations. For the Monte Carlo
simulation results, the 3-D matrix was sampled and I was able to obtain the
deposited dose in the chambers by calculating the average dose to water over
several voxels, corresponding to the active volume of the detector situated in
the positions where the chambers would be located. For each data set analysis,
the mean deviation was calculated as the difference between measured (dmeas,i)
and calculated dose (dcalc,i), normalized to the maximum beam dose (dmax)
and averaged over N IC positions i:
1
N
∑
i
|dmeas,i − dcalc,i|
dmax
% (4.2)
The number of points N included in the calculation can be equal or lower
than 24, depending on the data set.
For QA measurements, based on previously reported experiences with
actively scanned particles (Molinelli et al. 2013) in reference conditions, the
applied acceptance threshold was set to 5% for both mean deviation and
standard deviation over a data set. Both the mean and the standard deviation
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of the measurements were analysed. The reason for doing so was to benchmark
individual irradiation plan to obtained biological data.
In addition to the ionisation measurements and comparison, whenever the
film dosimetry was available, horizontal and vertical profiles were measured and
variations of the uniformity were assessed across x- and y- axes (perpendicular
to the cell compartment and beam). Uniformity was defined as the difference
between maximum and minimum values obtained for the optical density divided
by the their sum.
Uniformity = vmax − vmin
vmax + vmin
% (4.3)
Although this assessment provides a direct representation of the uniformity
of the delivered dose distribution, it is more susceptible to non-uniformities
owing to the films used and pixel defects in the reading scanner. Therefore,
another more useful assessment of uniformity is to evaluate the coefficient of
variance, which represents the spread that describes the amount of variability
relative to the mean. The coefficient of variation (CV) is defined as the ratio
of the standard deviation σ to the mean µ :
CV = σ
µ
% (4.4)
4.3.4 Technical Description
In this section the different experimental set-up for each measurement performed
will be described including, the Monte Carlo output used and the data analysis
performed.
The different irradiation plans are shown in Figure 4.1 and their technical
details are described in Table 4.1.
At CNAO, the phantom was irradiated with a uniform dose of 2.0 GyE for
protons and 3.0 GyE for the carbon plan, which corresponds to the clinical
fraction dose used for protons and carbon ions, respectively. The nominal
energy for the carbon plan ranged from 163.4 to 231.4 MeV/u with spot size
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ranging form 6.5 to 5.5 mm respectively, in a total of 51 energy steps for a total
of 3.0x109 particles. The LEM model was used for obtaining the RBE. For the
proton plan, the nominal energy range varied from 84.3 to 119.5 MeV with spot
size ranging from 15.4 to 11.5 mm in 49 energy steps for a total of 1.4x1011
particles. For protons, as mentioned above, the 1.1 RBE factor was used. Since
at CNAO only 12 chambers were available, the uniform dose distribution was
set to cover half of the phantom (as seen in Figure 4.1). In relation to depth,
the SOBP was set to be uniform (biological dose) in a section of 5 cm in the
middle of the phantom in order to have both build-up and exit dose areas within
the measurements. The decision was taken to use RBE-weighted dose for these
plans in order to evaluate the range uncertainty and the WEPL at different
conditions (sharp edge and gradient dose profile). In the case of protons the
deviation is more evident owing to the sharp edge and less so in the carbon
beam owing to the applied gradient along the SOBP.
Table 4.1. Technical description of experimental set-ups.
CNAO HIT
Experiment 1 Experiment 2 Experiment 3
SOBP 5 cm 10 cm 12 cm 5 cm
Dose Points 2.0 GyE (p) 0.5, 1.0 and 1.0, 2.0 and 1.0, 1.5, 2.0 and
3.0 GyE (12C) 3.0 Gy (12C) 4.0 (p, 12C) 4.0 Gy (p, 12C)
Number of 49 (p) 36 (p) 70 (p)
Energies 51 (12C) 74 (12C) 38 (12C) 74 (12C)
Detectors ion chambers ion chambers ion chambers ion chambers
and films and films and films
In this irradiation setting, each measurement data set consists of the si-
multaneous use of 12 ICs (PTW model 31015), connected by a multi-channel
precision electrometer (PTW Multidos). For each irradiation plan, at least two
consecutive measurements were performed and the mean values taken. EBT3
radiochromic films were also used to assess the uniformity of delivered dose
distribution. The films were placed at the beginning and end of the SOBP.
Three irradiations took place at HIT. In all measurements, the data set
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Cell 
compartment 
position
sensitive 
volume of 
detectors
A
B
C
D
E
F well  representation
Figure 4.1. Irradiation plan for the different experiments. Beam eye view from
experiment at CNAO (A), HIT experiment 1 (B) and HIT experiments 2 and 3
(C). Representation of depth dose profile along detectors. D for the experiment
at CNAO where the SOBP covers partially the detector positions; E for the
experiments at HIT 1 and 2 where the SOBP covers all detectors: and F for the
experiment 3 at HIT where only the central two wells are covered by the SOBP
and subsequently the detectors in the middle of the phantom. In both E and F
the representation of the well plate is visible. Uniform absorbed physical dose
has been used in the irradiation plans at HIT and RBE-weighted dose at CNAO.
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consisted of the simultaneous use of 24 ICs, connected by two multi-channel
precision electrometer (PTW Multidos).
In the first irradiation, the dose calculations were performed for 0.5, 1.0 and
3 Gy. The nominal energy for the carbon plan ranged from 88.8 to 255.8 MeV/u
with spot size ranging form 9.8 to 6.1 mm respectively, in a total of 74 energy
steps for a total of approximately 2.0x109 particles for each 0.5Gy delivered.
An uniform absorbed dose to cover the cell flask and detector positions was
used, as shown in the Figure 4.1.
At the second experiment at HIT the cell response was evaluated for both
carbon ion and proton beams in contrast to the previous experiments. The
delivered absorbed doses were 1.0, 2.0 and 4.0 Gy. The decision to use different
dose points in relation to the previous experiment were based on the fact that
different cell lines were being irradiated. The dose points were selected to
match those recommended in current literature for the new type of cell lines
used(further information can be found in the Chapter 5). The nominal energy
for the carbon plan ranged from 88.8 to 255.8 MeV with spot size ranging
form 9.8 to 6.1 mm respectively, in a total of 38 energy steps for a total of
approximately 2.0x109 particles for each 0.5 Gy delivered. The irradiation plan
was adapted in relation to the irradiation volume. In respect to the depth,
it continued covering the entire cell compartment (12 cm), but laterally it
was reduced to a margin of 2 cm around the cell compartment. An uniform
absorbed dose to cover the new irradiation target was used, as shown in Figure
4.1. Radiochromic films EBT3 were also used at two different depths, before
and after the cell compartment.
A third irradiation was performed at HIT. The nominal energy for the
carbon plan ranged from 88.8 to 255.8 MeV with spot size ranging form 9.8 to
6.1 mm respectively, in a total of 74 energy steps for a total of approximately
2.0x109 particles for each 0.5Gy delivered. In total, 4 irradiations for each
particle type was delivered (1, 1.5, 2 and 4 Gy). The irradiation plan was
adapted with respect to the SOBP position and length so as to evaluate the cell
survival in different positions along the beam path. With the new configuration,
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the SOBP was positioned in the centre of the multi-well cell plate covering the
two middle rows (5 cm). By doing so, I was still able to study cell survival
in relation to the LET variation along the SOBP as well as the entrance dose
(at the first row of the cell plate) and the exit dose (at the last row of the cell
plate) for different doses.
4.3.5 Specific Aims
In summary, the phantom was irradiated at different experiments. During the
different irradiations, different irradiation plans were set in order to evaluate
different aims. The aims for each experiment were as follows:
• Experiment performed at CNAO, whose results have been partially de-
scribed in Figure 3.12: The aim of this experiment was to validate
the computational tools and materials corrections applied in the dose
modelling.
• Experiment 1 performed at HIT: The aim of this experiment was the
evaluation of the phantom’s usability in a biological experiment and
revalidation of the new irradiation plan for a new facility.
• Experiment 2 performed at HIT: The aim of this experiment was the
evaluation of a new irradiation plan with reduced irradiation volume.
• Experiment 3 performed at HIT. The aim of this experiment was the
evaluation of a full radiobiological experiment, including clonogenic cell
survival, a reduced irradiation target along the SOBP and improved
uniformity.
Figure 4.2 gives a overview of the different experiments including aims and
beam information. The complete description of each experiment including
information on the beam description, performed dosimetry including detector
corrections have been described above and the obtained results can be found
below.
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Figure 4.2. An overview of the characteristics of the different experiments performed
with the phantom.
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4.4 Results
This results section will describe the outcome for each aim set forth in Section
4.3.5. The overall discussion of the results will be covered in the conclusion.
4.4.1 CNAO Results - MC Simulation Benchmark for
the First Irradiation Plan including Verification
of WEPL Correction
Film Measurement Firstly, an analysis of the uniformity of the delivered
beam at different depths was conducted using the radiochromic films. This
procedure was performed for all the depths from 1 to 9cm with 1cm steps.
Figure 4.3 shows the obtained results for the first and penultimate films for the
12C ion beam irradiation. These steps were chosen as they represented both
the first and last beam within 80% of the SOBP. At each depth, the optical
density for each pixel value (top) and the calculated difference (bottom) was
obtained. The plot at the top also displays the uniformity and the coefficient
of variance that were calculated as per Equations 4.3 and 4.4. This uniformity
in then expressed in the bottom plot as dashed lines.
The optical density was obtained by two profiles with sampled normalised
values in two orientations represented by the blue (horizontal) and red (vertical)
lines. The calculated uniformity for the first film was 1.77% and CV of 0.61%.
The uniformity for the penultimate film was 2.01% with CV equal to 0.63%.
As expected, greater variation in the uniformity was observed towards the end
of the SOBP, mostly owing to the introduction of the ionisation chambers. The
CV was able to represent a general information about the uniformity, which is
the reason for a lower variation.
The same analysis was repeated for the proton beam (Figure 4.4).
Greater variation was also observed at greater depths, although in contrast
to the 12C, proton uniformity was noticeably poorer. This is the result of the
greater scatter and beam spreading which proton beams are more susceptible
CHAPTER 4. DOSIMETRIC MEASUREMENTS 93
0.7
0.8
0.9
1.0
1.1
1.2
1.3
N
o
rm
a
lis
e
d
 O
p
ti
ca
l 
D
e
n
si
ty Uniformity 1.77
CV 0.61
Vertical Profile
Horizontal Profile
0 20 40 60 80 100
Sampled Points
4
2
0
2
4
D
if
fe
re
n
ce
 (
%
)
0.7
0.8
0.9
1.0
1.1
1.2
1.3
N
o
rm
a
lis
e
d
 O
p
ti
ca
l 
D
e
n
si
ty Uniformity 2.01
CV 0.63
Vertical Profile
Horizontal Profile
0 20 40 60 80 100
Sampled Points
4
2
0
2
4
D
if
fe
re
n
ce
 (
%
)
Figure 4.3. Uniformity analysis of the delivered12C ion beam at first film placed
at the beginning (top) and at the end (bottom) of the SOBP. Top - obtained
optical density for each pixel value; bottom - calculated deviation. The calculated
uniformity has been annotated in the top plot and then expressed as dashed lines
in the bottom plot.
to.
The reason for using the films was to assess the uniformity of the delivered
dose distribution on the regions where the chambers were not present. Hence a
new analysis of the uniformity was performed without the distortion from the
ionisation chambers.
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Figure 4.4. Uniformity analysis of the delivered p beam at film placed at the
beginning (top) and at the end (bottom) of the SOBP. Top - obtained optical
density for each pixel value; bottom - calculated deviation. The calculated
uniformity has been annotated in the top plot and then expressed as dashed lines
in the bottom plot.
The final calculated uniformity for the proton beam was between 2.30% in
the beginning of the SOBP and 3.21% in the end part of the SOBP.
Ionisation Chamber Measurements Figure 4.5 compares each measure-
ment taken with the ionisation chambers in relation to the calculated dose from
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the MC simulation and TPS. For both beam qualities, the measured doses
are listed in Table 4.2. The results were compared to the expected dose of
2 GyE and 3 GyE for protons and carbon ions respectively. The mean dose
differences of 1.74% for protons and 1.37% for carbon ions were within the
estimated total uncertainties of ionisation chamber measurements based on
uncertainty budgets from TRS-398 recommendations.
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Figure 4.5. Comparison between measurement and MC simulations for 12C ion
beams and p, left and right respectively.
These results, together with the data collected from the aforementioned
procedures (Section 4.3.3), were used as a means of analysing the average and
standard deviation of the measurements. These results also lay well below
the local CNAO quality assurance acceptance levels of 5% obtained deviation
between physical dose measurements and calculations.
The observed difference between p and 12C results were a result of the
worsening broadening of the beam suffered by the protons since the uniformity
at that depth was more affected than during irradiation as expected. This
caused the increased deviation observed (Table 4.2, Figure 4.3).
Table 4.2. Obtained dose deviations from measurements
for each beam type.
Average(%) Std. Dev. (%) Max (%)
Carbon 1.37 0.80 2.60
Protons 1.74 1.04 3.78
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4.4.2 Evaluation of biological usability of the phantom
and re-validation of irradiation plans Results
Experiment 1 at HIT- Evaluation of Phantom Usability in a Bio-
logical Experiment and Re-validation for a New Facility and New
Irradiation Plan.
Ionisation Chamber Measurements - As described previously, during
this experiment only ionisation chambers were used for measurements. This
was owing to the fact that the experiment served as basis for testing the
usability and user-friendliness of the phantom as a biological dosimetric tool.
The HIT’s quality assurance procedures were followed (Karger et al. 1999) and,
similarly to the experiments conducted at CNAO, the resulting measurements
were compared to the dose calculation using MC simulations (Table 4.3).
Table 4.3. Obtained dose deviations from measurements at HIT.
Dose (Gy) Average (%) Std. Dev. (%) Max (%)
12C 0.5Gy 2.16 1.11 5.51
1.0Gy 1.39 1.15 5.10
3.0Gy 1.86 1.54 4.03
In a similar manner to the aforementioned experiments conducted at CNAO,
these results fell well within QA acceptance levels of 5% , which consequently
helped to obtain a good agreement with detector measurements and subse-
quently obtained cell survival. This allowed for a full dosimetric assessment
(Desrosiers et al. 2013) and beam characterisation with dose calculating tools
to be performed.
Experiment 2 at HIT - Evaluation of New Irradiation Plan with
Reduced Irradiation Volume
Film Measurement - An analysis of the uniformity of the delivered beam
at different depths was conducted using radiochromic films.
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This procedure was performed before and after the cell compartment at two
depths, of 0.95 and 13.65 cm, respectively. During this experiment, films could
only be placed before and /or after the cell compartment due to the presence
of the cell container. As previously described for the other experiments, from
each of these films the normalised optical density for each pixel value (top) and
the calculated difference (bottom) were calculated and plotted. The top plot
also displays the uniformity and the coefficient of variance that were calculated
as per equations 4.3 and 4.4. This uniformity is then expressed in the bottom
plot as dashed lines.
Figure 4.6 shows the obtained results for both films used for the 12C ion
beam irradiation. The optical density was obtained by two profiles sampled
normalised values in two orientations represented by the blue (horizontal profile)
and red (vertical profile) lines. The calculated uniformity and CV for the first
film were 4.83% and 1.69%, respectively.
The uniformity for the last film was 3.42%, while the calculated CV was
1.41%.
Figure 4.7 shows the obtained results for both films used for the protons
beam irradiation. The optical density was obtained using two profiles along
two orientations represented by the blue (horizontal profile) and red (vertical
profile) lines. The calculated uniformity and CV for the first film were 4.44%
and 1.60%, respectively.
The uniformity for the film on the end of the protons beam path was
2.34% while the calculated CV was 0.80%. As discussed aforementioned, the
uniformity describes deviations associated with pixel values, but it can be
incorrect if there are unresponsive pixels during the scanning process of the film.
The representation of the CV therefore would be indicative of the uniformity
of the film. From these results, a small CV was obtained signalling a small
fluctuation in the lateral dose deposition.
Ionisation Chamber Measurements - As described previously, only ioni-
sation chambers were used for measurements during this experiment. This was
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Figure 4.6. Uniformity analysis of the delivered 12C ion beam at a film placed
at the beginning (top) and end (bottom) of the beam path. Top - obtained
normalised optical density for each pixel value; bottom - calculated deviation.
The calculated uniformity has been annotated in the top plot and then expressed
as dashed lines in the bottom plot.
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Figure 4.7. Uniformity analysis of the delivered protonbeams at a film placed at the
beginning (top) and end (bottom) of the beam path. Top - obtained normalised
optical density for each pixel value; bottom - calculated deviation. The calculated
uniformity has been annotated in the top plot and then expressed as dashed lines
in the bottom plot.
owing to the fact that this experiment served as basis for testing the usability
and user-friendliness of the phantom as a biological dosimetric tool. Therefore
the HIT’s quality assurance procedures were followed (Karger et al. 1999) and,
similarly to the experiments conducted at CNAO, the resulting measurements
were compared to the dose calculation, in this case MC simulations (Table 4.4).
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Table 4.4. Obtained dose deviations from measurements for each
beam type.
Dose (Gy) Average (%) Std. Dev. (%) Max (%)
1.0Gy 1.91 1.32 4.4
12C 2.0Gy 1.92 1.25 3.6
4.0Gy 1.97 1.59 4.65
1.0Gy 1.16 0.91 2.4
1P 2.0Gy 1.05 0.85 2.35
4.0Gy 1.05 0.76 2.25
In a similar manner to the aforementioned experiments conducted at CNAO,
these results fell well within QA acceptance levels of 5%, which consequently
helped to obtain a good agreement with detector measurements and ensured
cell survival. This allowed for a full dosimetric assessment (Desrosiers et al.
2013) and beam characterisation with dose calculating tools to be performed.
Experiment 3 at HIT - Evaluation of a Full Radiobiological Exper-
iment including Reduced Irradiation Target along the SOBP and
Improved Uniformity.
Film Measurement - An analysis of the uniformity of the delivered beam
was conducted at only one depth (z = 0.95 cm) using radiochromic films. The
choice of analysing only one depth in comparison to the two depth approach
used at previous experiments was due to the length of the SOBP. During this
experiment, the SOBP covered solely the central part of the cell compartment
and a film at the end of the cell compartment would not detect anything. In this
experiment, films could only be placed before and/or after cell compartment
due to the presence of the cell container. As previously described for the other
experiments, the normalised optical density for each pixel value (top) and the
calculated difference (bottom) are calculated and plotted from each of these
films. The top plot also displays the uniformity and the coefficient of variance
that were calculated as per Equations 4.3 and 4.4. This uniformity in then
expressed in the bottom plot as dashed lines.
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Figure 4.8 shows the obtained results for both the carbon ions (left) and
protons (right) irradiations films used. The optical density was obtained by
using two profiles along two orientations represented by the blue (horizontal
profile) and red (vertical profile) lines. The calculated uniformity and CV
was 2.13% and 0.92% and 2.18% and 0.87%, respectively for carbon ions and
proton.
Ionisation Chamber Measurements - As described previously, the ioni-
sation measurements were compared to the dose calculation, in this case MC
simulations. Table 4.5 shows the obtained dose deviation for each irradiation
plan.
Table 4.5. Obtained deviations from measurements for each beam
type.
Dose (Gy) Average (%) Std. Dev. (%) Max (%)
1.0Gy 2.33 0.94 4.70
1.5Gy 2.35 0.98 4.47
12C 2.0Gy 2.35 0.96 4.35
4.0Gy 2.39 1.22 4.25
1.0Gy 1.54 1.40 4.09
1.5Gy 1.57 1.45 4.27
1P 2.0Gy 1.49 1.46 4.25
4.0Gy 1.57 1.36 3.83
These results for this new plan also fell well within QA acceptance levels
of 5%, which consequently helped to obtain a good agreement with detector
measurements and ensured cell survival. The average deviation was below 2%
for both ion types and all irradiation plans.
4.5 Discussion
The work applied in this thesis describes the importance of improved dosimetry
for radiobiological experiments. In this chapter the different contributions and
limitations to the physical measurements of the dose were discussed along with
the relevant implications in radiobiological experiments. The viability study
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Figure 4.8. Uniformity analysis of the delivered carbon (top) and proton (bottom)
ion beams at a film placed at the beginning of the beam path. Top - obtained
normalised optical density for each pixel value; bottom - calculated deviation.
The calculated uniformity has been annotated in the top plot and then expressed
as dashed lines in the bottom plot.
of the phantom for biological assessments is covered in the next chapter. In
Chapter 2, the necessity for an improved design was introduced. It was found
that in order to reduce uncertainties associated with radiobiological experiments
the following steps must be taken:
• Improved dosimetry during cell culture irradiation; and
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• Reduced introduction of additional biological uncertainties either by not
disturbing the beam path in order to perform these needed dosimetry
or by performing in-house sterilisation of tools in contact with cells and
uncertainties with batch effect.
The novelty of this phantom is the ability to account for these points
in its design conception, in addition to being user-friendly and easily trans-
portable. Concerning the dosimetric limitations of current design, a recent
review (Desrosiers et al. 2013) identified dosimetry, or the lack of it, as the
main concern for the reliability of radiobiological experiments. The authors
were mainly concerned with animal work but the same can be said about cell
irradiations. This improvement in dosimetry is even more important in the
field of scanned particle beams where uncertainties associated with the physical
and biological properties of the ion beam and modern delivery techniques are
challenges for the delivery of the correct dose (Carabe et al. 2012; Paganetti
2012).
A weakness of the phantom is the fact that a relative big volume must be
irradiated in order to obtain uniform dose along the cell compartment and
detectors which results in increased irradiation time.
The experiments at CNAO and HIT showed that a good agreement is
obtained between dose calculation and ionisation measurements even when
varying the dose distribution by delivering a less uniform irradiation plan, and
thereby reducing the irradiation time. This agreement was evaluated at different
uniformity levels during the experiments and ranged from 2.30 and 1.70 %
for protons and carbon irradiation respectively, during the first experiment in
CNAO, to 4.44 and 4.83 and 2.18 and 2.13 % for protons and carbon for the
second and third experiment, respectively.
Figure 4.9 describes the aims of the different experiments and highlights
some of the obtained results and next steps.
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Figure 4.9. An overview of the characteristics of different experiments performed
with the phantom including some of the obtained results and next steps.
The aim of the experiment performed at CNAO was to obtain the WEPL so
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as to correctly account for the material description in the dose calculations. The
results obtained demonstrated that a good agreement was obtained between
dose measurements and MC simulations. Each irradiation facility required
re-validation of dose calculation tools in order to correctly simulate the dose
distribution. Since the phantom material was kept the same, the re-validation
was only in respect of the dose delivery system.
During the first experiment at HIT, this re-validation was tackled and a
good agreement was obtained with an average deviation in the order of 2.16%.
Before the second experiment at HIT, the phantom was modified in order to
be able to accommodate extra radiobiological commercial tools for improved
spatial resolution in the cell survival results. Initially, T25 cell flasks were
used and after the modification the phantom was capable of accommodating
multi-well plates. The multi-well plates enable the survival analysis to be
conducted at different positions, thereby increasing the spatial resolution of
the cell survival results. Due to the increased length of the cell compartment,
the irradiation plan was modified. With this new irradiation plan, a good
agreement was still obtained at the second experiment at HIT this time with
both ion types (the worst mean deviation between ionisation chambers and dose
calculations were 1.16 and 1.97 % for protons and carbon ions, respectively).
This demonstrates that the irradiation plan was ready to be used in the full
radiobiological experiment.
During the last irradiation experiment at HIT, the agreement between
measurement and dose distribution modelling was still within acceptable values.
As discussed by Ableitinger et al. 2013, for scanned ion beams there are no
established criteria for agreement between measurements and calculations and,
as the authors suggest, the most reasonable analysis of these criteria was
performed by Jaekel et al. 2000. According to these recommendations, the
mean value of deviations between measured and calculated doses should be less
than 3%, while the maximum deviation should be less than 5% for a target
volume in a homogeneous medium.
The mean deviations from the irradiations performed are given in Table
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4.2 to Table 4.5, and are in compliance with these proposed criteria. However,
since the phantom is not completely homogeneous, nor the irradiation plan
completely uniform, the criteria regarding the maximum deviation was not
always achieved. During the first irradiation performed at HIT for carbon
ion beams one measurement at both 0.5 and 1.0 Gy exceeded this maximum
deviation criteria, 5%. During the second and third experiments at HIT, a
higher uniformity setting was selected during irradiation plan calculation steps
and compliance with this criteria was also achieved. Another weakness of
these irradiations are that the irradiation plan calculations were performed
with the TPS and these dose calculation algorithms are noticeable limited in
calculating dose deposition in non-homogeneous targets. However, the phantom
was designed with this limitation in mind and the results showed a good
agreement at different positions along the beam path.
Although the influence of dose modelling by MC simulation uncertainties
cannot be ignored, the biggest limitations for the irradiation plans used lay with
the measurements in addition to the inhomogeneities within the irradiation
target. I previously demonstrated that MC simulation is capable of reproducing
the reference experimental conditions (Figure 3.4) at a high precision.
During all comparisons of the irradiation experiments in this thesis, the gold
standard was considered to be the ionisation chambers results, but this could
also be considered a possible limiting factor since these detectors are not capable
of correctly measuring dose in high gradient regions due to the lack of charged
particle equilibrium conditions in some regions. This would explain deviations
between the calculated and measured absorbed dose (Sanchez-Doblado et al.
2007). This was visible, in the exit dose regions for example. Figure 4.5 showed
poor agreement is obtained for the last ionisation chamber positions (10 and
11). Overall, as previously discussed, a good agreement between measurement
and dose calculation was achieved. The same behaviour of poor agreement at
some dose points were also observed for the last two experiments performed at
HIT where the maximum deviation was found to be on the detectors in low
gradient regions. Another limiting factor was the dose calculation performed
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by MC simulations. I was able to show that in most cases, the MC simulation
presented precision level beyond the accuracy of the experimental measurements
(within ± 3% mean deviation and ± 5% maximum deviation for 90% of the
irradiations).
In the previous chapter, I demonstrated that with this phantom design I
was able to improve dosimetric recording in comparison to all other set-ups
described in Chapter 2, either by not introducing uncertainties in the dose
deposition in the cell compartment region, or by correctly evaluating the dose
profile which in certain cases could amount to 2.5% (Molinelli et al. 2013).
The aim of this chapter was to validate the irradiation plan at different stages
by analysing the dosimetric output of the phantom. By doing so, I was able
to validate the dose calculation for the whole target area of the phantom so
as to correctly report the irradiation dose applied to the cell compartment.
This enabled me to study cell survival at the cell compartment with improved
dosimetric information on the irradiation beam. By using MC simulations I
was able to evaluate different physical and biological outputs such as LET and
biological dose.
By using validated MC simulations of the irradiation plan, the phantom
was able to report the deposited dose to the cell compartment with a higher
confidence level than the ones reported (when reported) in other experiments
(Combs et al. 2012; Elsaesser et al. 2010; Bert et al. 2010; Mitaroff et al. 1998;
Barazzuol et al. 2012).
The next chapters will go on to discuss the biological evaluation of the
phantom, its performance in a radiobioloigcal experiment, including RBE
reporting, and the future steps.
4.6 Conclusions
The results presented in this chapter demonstrate that a good agreement
between the irradiation plans and measurements is obtained (within ± 3%
mean deviation and ± 5% maximum deviation for 90% of the irradiations).
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This enabled the MC dose calculation to be benchmarked at these different
irradiation plans. With this information, cell survival could be correlated
and evaluated with other physical and biological outputs obtained by the MC
simulations for the cell compartment.
These results showed that the proposed phantom is able to correlate the
calculated dose at specific points calculated by the MC simulation with the
measurements and therefore is able to improve dosimetric reporting in the cell
compartment, especially for cases where no information is provided or certain
uncertainties are not considered. The phantom therefore has been shown to
improve dose reporting and reliability in radiobiological experiments. The level
of confidence in the reported dose can be thus improved by optimising the
beam uniformity.
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Chapter 5
Biologic Measurements of
Photon and Hadron Beams
5.1 Aim
The aim of this chapter is to evaluate the use of the phantom in assessing
the biological response of one cell line for different radiation types. In general
owing to the chosen irradiation orientation of the phantom, the radiobiological
results were evaluated for the LET and dose parameters in terms of cell survival.
In the case of the work contained in this thesis, the contribution of the dose
and LET to cell survival is paramount. As well as being able to evaluate
multiple parameters by accommodating commercially available cell chambers.
This latter feature enables simultaneous irradiation of multiple cell cultures,
prepared in the same conditions, thereby reducing the biological variability
that would otherwise occur if these experiments were spread over several days.
In the previous chapter, it was shown that thanks to the dosimetric reporting
of the phantom, I was able to correlate the dose calculation obtained from
MC simulations to the ionisation measurements within 3%. The uncertainty
was lower than that of the ionisation chamber for proton and carbon ions.
With this information about dosimetry across the phantom alongside the
proposed statistical reporting method, cell survival and different parameters of
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the phantom could be evaluated in radiobiological experiments.
The main objective of this chapter therefore is to evaluate the behaviour of
the cell survival results obtained by the phantom in radiobiological experiments
with respect to RBE and LET.
5.2 Introduction
The success or failure of a treatment is characterised by the relationship between
the Tumour Control Probability (TCP - the chance of overcoming the disease),
and the Normal Tissue Complication Probability (NTCP - the chance of
complications arising in normal tissues arising from the amount of side effects
the treatment is conferring). Therefore, in order to improve treatment efficacy,
either the TCP needs to be increased and / or the NTCP needs to be reduced.
This can mainly be achieved by either improving:
• Physical parameters of the treatment, for example by improving the dose
delivery conformity (Jones et al. 2009; Durante 2014); or
• Biological parameters (properties) of the tissues, for example by improving
oxygenation (Tinganelli et al. 2013) in order to increase radiosensitivity
of hypoxic tumours cells.
In a recent publication (Wera et al. 2013), the authors showed that LET
variations are present within the tumour volume due to continuous energy
loss along the proton track, and therefore, the associated RBE may be higher
or lower than the standard 1.10. This constant RBE value is currently used
clinically in the TPS and it is supported by international guidelines (ICRU
2007). This problem of evaluating the effectiveness of ions (including protons)
is not limited only to quantifying LET, but also to understanding that different
radiation qualities may also differ in the type of induced biological damage
caused (Niemantsverdriet et al. 2012). All these issues raise the need for further
cell irradiation experiments with different cell lines and different end points.
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The review described in Chapter 2 showed that, in order to improve our
knowledge of enhanced radiobiological effectiveness, which is necessary to
support clinical proton and ion beam applications, more dedicated tools need
to be developed. The main characteristic pursued for the phantom was the
ability to have both physical and biological measurements in a device which is
transportable and has lower complexity for usage and analysis of results. The
phantom aims to facilitate high-throughput data acquisition from biological
samples prepared in the desired experimental setting. This ability to perform
multiple irradiations in the smallest amount of time is important biologically
(to reduce possible biological differences (Leek et al. 2010)), but also logistically
as indicated by a recent review (Abler 2012) which showed that there is a
significant lack of beam time availability for radiobiological research with ion
beams including protons.
The following section aims to show that the phantom is capable of evaluating
biological response in relation to both dose and LET in a manner relevant to
clinical treatments, as suggested by Paganetti 2014; Jones 2015a; Jones 2015b.
Such a phantom also allows for evaluation of different biological end points in
simpler radiobiological experiments.
5.3 Methods
Cells were irradiated with ions (protons and carbon ions) at HIT and with
6MV X-rays (photons) at the German Cancer Research Centre or Deutsches
Krebsforschungszentrum (DKFZ) (experiment 2 and 3 at HIT described in
previous chapter). DKFZ is a national research centre located in Heidelberg with
research focused on cell biology and tumour biology; structural and functional
genomics; cancer risk factors and prevention; tumour immunology; imaging and
radiobiology; infection and cancer, and translational cancer research. HIT is a
hospital-based ion beam therapy facility which is connected to the neighbouring
clinical departments of the Heidelberg University Hospital.
I carried out the work for all the experiments (during all stages from imaging,
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planning and irradiation) and analysis of the dosimetry. For the biological steps
(seeding, plating and counting) assistance and equipment(incubator, flasks,
pipette and cell medium) excluding the multi-well plates were provided by the
Dr. Dokic. Once the cell survival was obtained, I perform all curve fittings and
data analysis of the different biological assays.
In this thesis, the cell line A549, a human Non-Small-Cell-Lung-Carcinoma
(NSCLC) cell line, was irradiated at different experiments. Despite the im-
provements in conventional radiotherapy, overall survival for advanced stages
of lung cancer is still small (in the region of 15%). Wink 2014 has suggested
that the limiting factor to dose escalation, and therefore better tumour control
probability, is the proximity for healthy tissues at risk (lung, heart, mediastinal
structures, spinal cord) and that the improved conformity achieved with particle
therapy (protons, carbon, etc.) makes these techniques an option worthy of
investigating. In addition, the treatment of more challenging tumours like lung
carcinomas, which can prove difficult to target owing to movement, is seen as
the next step in obtaining recognition for modalities of high precision delivery
such as particle therapy (Bert et al. 2010; Riboldi et al. 2012). These factors
influenced the availability of this cell line in the radiobiological laboratory used
for the cell preparation and analysis in my thesis.
The dosimetric information of each experiment has been previously described
in detail in the previous chapter (Chapter 4). The main differences between
irradiations were the shortened SOBP during the second experiment in respect
to the first (12 vs 5 cm). This was done by reducing the energy range between
experiments (energy range from 88.8 to 272.8 MeV per nucleon for the first
experiment for carbon ions and 88.8 to 216.0 MeV/u for the second experiment).
At both experiments, dose deposition was obtained with ionisation chambers
and compared with Monte Carlo simulations. Cells were prepared and irradiated
at two independent experiments. The first experiment served as preparation
for the second experiment in terms of optimising cell seeding (Section 5.3.1),
where the same preparation and analysis were used. In addition, at both ion
irradiations a target volume as described in Section 4.3.4 was irradiated with
CHAPTER 5. BIOLOGICAL MEASUREMENTS 113
a uniform physical dose. During a second experiment, in addition to the ions
irradiations at HIT, X-ray irradiation was performed at DKFZ as a baseline
for subsequent RBE calculations. The experimental pathway is described in
Figure 5.1 below.
Imaging
Dose  
Planning
Irradiation
BiologyPhysics
Beam uniformity
Dose points/ profile
Range verification
Clonogenic Assay
Dose
Dosimetric  
Information
Cell Response
LET
Novelty of 
the Phantom
Figure 5.1. Schematic Representation of Experimental Pathway. The novelty of the
phantom is the possibility to correlate different physical attributes to biological
responses in simpler set-ups.
As previously discussed in Section 4.3.3 the phantom followed the patient
protocol of both locations. Firstly, it was imaged (CT) and had external
surrogates placed for reference localisation when irradiating. The images
with localisers were than transferred to the TPS where different irradiation
plans were calculated for the different dose points and particle type. The
calculated irradiation profiles were transferred to the respective accelerators
and irradiation was conducted. Irradiation plans for all ion experiments were
carried out by the CE-marked syngo® RT Planning by Siemens AG Healthcare
(Erlangen, Germany) and the CE-marked RayStation® 4.5 system by RaySearch
Laboratories AB (Stockholm, Sweden) at DKFZ.
For each irradiation, dose deposition information was acquired for the
different detector positions and cell survival analysis was performed. The novelty
CHAPTER 5. BIOLOGICAL MEASUREMENTS 114
of this phantom design is its ability to obtain both dosimetric (beam uniformity,
dose points or profile and range verification) and biological (clonogenic assay
and multivariate correlations for example RBE-LET-Cell survival) information
during the irradiation and, by doing so, it is able to facilitate radiobiological
experiments.
5.3.1 Cell Preparation
Human A549 cells were grown in complete growth medium (cDMEM) containing
10% Foetal Bovine Serum (FBS). For these experiments, commercially available
multi-well plates were labelled in preparation for setting up each plate with a
known number of cells depending on the radiation dose given. Seeding densities
for different delivered dose points are presented in Table 5.1.
The different cell seeding was chosen so that after irradiation a reasonable
number of surviving colonies could be observed, on the understanding that if
a standard deviation should be in the order of 10%, the number of surviving
colonies minus 10% would be greater than zero. It was chosen empirically
as it has shown that those numbers will give sufficient countable number of
colonies (enough to be seen by eye, also to decrease the deviations, and not
to have them too many since they would start fusing one with another and
we could not distinguish them) where the goal is to have similar number for
counting for each sample (dose). The numbers are also dish-dependent (smaller
wells less cells to avoid fusion, but to have still enough cells for counting also
at high dose where we kill a lot). It was noted that the cell seeding between
experiments was reduced. This was due to the number of large clustered
colonies found in the first experiment. A balance was therefore struck on the
second experiment between having enough cells to produce a reasonable number
of colonies and having too many cells to avoid clustering of colonies which
introduce uncertainties in colony counting. A threshold of 50 cells per colonies
was used in this thesis and colonies containing below that number of cells were
not counted.
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Before irradiation, the cell medium was removed, and the cells were briefly
rinsed with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces
of serum that contains trypsin inhibitor, and this solution was extracted. New
Trypsin-EDTA solution was added to the flask in order to detach and disperse
the cell layer. Once this was verified by visual inspection on a microscope,
complete growth medium was added and cells were aspirated by gently pipetting.
Cells were counted with a Neubauer chamber and appropriate aliquots of the
cell suspension were transferred to multi-well plates. Once the correct seeding
ration was obtained, the different cell densities were placed in their respective
plate. The plates were then placed in a 37◦C incubator set at 5% carbon
dioxide (CO2) to allow the cells to settle and attach as a mono-layer prior to
irradiation.
Table 5.1. Cell seeding - Number of cells used in irradiation experi-
ments.
Carbon Ions Proton Ions X-rays
Exp 1 - Exp2 Exp 1 - Exp 2 Exp 1 - Exp 2
0 Gy (Control) 100 - 100 * n/a - *
1.0 Gy 400 - 200 400 - 100 n/a - 100
1.5 Gy n/a - 200 n/a - 100 n/a - n/a
2.0 Gy 400 - 200 400 - 200 n/a - 100
3.0 Gy n/a - n/a n/a - n/a n/a - 100
4.0 Gy 1000 - 400 1000 - 200 n/a - 200
6.0 Gy n/a - n/a n/a - n/a n/a - 400
8.0 Gy n/a - n/a n/a - n/a n/a - 400
* - same control was used for all cell irradiation in the same experiment.
n/a - not applicable, or not used.
5.3.2 Cell Analysis
Cells were seeded in 10% FBS/cDMEM in 12-well plates and irradiated 24
hours later, followed by a 7-10 days’ incubation. Clonogenic assay (Franken
et al. 2006) was performed to assess the biological response from the irradiated
dose. The number of visible colonies was manually counted after being fixed
with 75% methanol and 25% acetic acid for 10 minutes at room temperature
and stained with 0.1% crystal violet for 15 minutes.
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The plating efficiency (PE) was obtained from the control (uniniradiated)
sample (Equation 5.1), and surviving fractions (SF) calculated using this
information from the number of surviving colonies in irradiated samples and
the PE (Equation 5.2).
PE = Nc
Np
x 100 % (5.1)
SF = Nc
Np x PE
% (5.2)
Where Nc and Np correspond to number of counted colonies and number of
plated cells respectively.
The survival curve was obtained from three different wells, which corresponds
to three survival values per dose as shown in Figure 5.2 below. Errors were
evaluated as standard deviations. Mock irradiated cells were used as a control.
12 Multi-Well Plate
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Figure 5.2. Multi Well Plate Irradiation Diagram. Each row (1,2,3 and 4) represents
one dose point and cell survival was obtained from three different wells (A, B
and C). Errors were evaluated as standard deviations.
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5.3.3 Irradiations
The previous prepared multi-well plates (Section 5.3.1) were placed in front of
the beam-eye view inside of the phantom. The irradiation field is centred at
the isocenter. The full details of the dosimetry used in the ion irradiations are
described in the previous chapter (Section 4.3.4). The relevant information for
this chapter has been included below. In addition to the ion irradiations, during
the second experiment at HIT, some cells were separately irradiated with X-rays.
The details of this irradiation are described in the following sections and Figure
5.3 summarises the outline of these experiments. A graphical description of
the phantom and beam orientation is found in Appendix A.
Experiment 1 Experiment 2
Biology A549  (12 Multiwell plates)
Radiation  
types p and C-12
p, C-12  
and x-rays
Dose  
Points 1, 2, 4 Gy
1, 1.5,  2, 4 Gy 
 (for p and C-12) 
1, 2, 3, 4, 6 and 8 Gy 
(for x-rays)
Output SF SF, RBE estimation  and LET variability
A549  
(12 Multiwell plates)
Figure 5.3. Outline of biological experiments. The main difference between the
experiments is that during the second experiment as X-ray survival was also
obtained, RBE and possible correlations between RBE-SF-LET were evaluated.
Experiment 1 - Evaluation of Biological Set-up.
As aforementioned, an initial experiment was conducted at HIT so as to evaluate
the experimental set-up. During this experiment the cell response was evaluated
for both carbon and proton ions. A uniform physical dose along the SOBP
with delivered doses of 1.0, 2.0 and 4.0 Gy was used. During this experiment
the whole multi-well plate was irradiated with the same dose. The complete
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irradiation plan and dosimetry information are described at Section 4.3.4.
Experiment 2 - Viability Study of the Phantom for Radiobiological
Experiments.
Experiment 2 was performed at two different centres: DKFZ due to its avail-
ability to a clinical X-ray linear accelerator and HIT where ion beam irradiation
take place.
DKFZ At the DKFZ, a Siemens medical linear accelerator (or Linac) was
used. One irradiation plan was created for a selected dose and the subsequent
plans for the different doses were obtained by scaling the delivered monitor
units to the reference point. For the X-ray measurements, a 6 MV photon beam
was used. In total 6 dose points were performed (1.0, 2.0, 3.0, 4.0, 6.0 and 8.0
Gy) for a field of 10 cm by 10 cm. The reference point was placed in one of the
multi-well rows, and the surviving fraction were used from the results of this
specific row. The irradiation beam was oriented horizontally to the cell culture
plate as shown in Figure 5.4. The 97%-105% dose was positioned along the
second row of the multi-well plate.
Figure 5.4. Beam orientation by the irradiation plans at DKFZ measurements.
Proposed orientation used by ion irradiations where the cell plate is positioned
horizontally to the beam direction.
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Two different dosimeters have been used in the phantom during this experi-
ment: films and an ionisation chamber. GafChromic films were placed before
and after the cell plate and the ionisation chambers were located at the mid
point of the plate in relation to the depth, which corresponds to the reference
point used by the TPS for the preparation of the irradiation plan. PMMA
inserts were also used to avoid inhomogeneities along the beam path.
HIT During this second irradiation at HIT, similar to the previous exper-
iments, different dose points for both carbon and proton ions were used to
evaluate the cell response. During this experiment, a uniform physical dose
along the selected section of the SOBP with delivered doses of 1.0, 1.5, 2.0 and
4.0 Gy was used. An extra dose point (1.5 Gy) was selected, in addition to the
doses used during previous experiment, since the results obtained previously
showed a possible curvature of the fitted survival curve that was could not be
fully measured in the region between 1.0 and 2.0 Gy. This extra dose point
further reduced uncertainties in the fitting.
As shown in Table 5.1, the seeding was reduced in order to compensate for
the cell growth owing to the waiting time for cell counting. In addition, the
two middle rows of the multi-well plate were irradiated with the same dose.
The first and last row received the entrance dose and the exit dose respectively.
The complete irradiation plan and dosimetry information are described at
Section 4.3.4. The reason for choosing this reduced SOBP was to evaluate if
the procedure of the irradiation plan and dose delivery was able to correct
correlate different cell survival at different delivered doses per cell plate.
5.3.4 Dosimetry and Beam Characterisation
The evaluation of the dosimetry and beam characterisation in the cell compart-
ment was carried out after the irradiation using either MC simulations or TPS
as previously described (see Section 3.2.1). FLUKA is capable of simulating
both ions and X-rays, but for the purpose of this thesis only ions have been
simulated. For X-rays, the dose calculation done by the TPS was used. Ioni-
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sation chambers, or other chosen detectors, allow for verification of the dose
distribution (in relation to beam range and dose deposition) and subsequently
assist with MC simulation benchmarking. The obtained correlation between
dose modelling (via MC) and measurement were within the limitations of the
detector (below 3%).
5.3.5 Data Fitting and RBE Calculation
Calculation of LET-RBE Variability
The statistical approach set forth in Section 2.4.1 was used in order to obtain
the new optimised α and β parameters and RBE confidence interval.
In addition to the calculation of the clonogenic cell survival subsequently
for the viability study, the LET-RBE variability was also investigated. The
method previously described by Jones et al. 2006was used.
RBEs were calculated by comparing the single doses in order to obtain an
isoeffect:
αLdL + βLd2L = αHdH + βHd2H (5.3)
where, L and H are related to low or high LET respectively. Then it is just
needed to divide the equation by the dH . The α and β were obtained by the
optimisation of the fitting survival fraction curves.
5.4 Results
5.4.1 Assessment of Cell Survival
Experiment 1 - Evaluation Study
The measured cell survival for carbon ion irradiation in the first experiment is
shown in Table 5.2. The survival was obtained from each well for all multi-well
plates. From each row, a mean cell count was obtained. Once the plating
efficiency was calculated the mean cell survival (µ) and one standard deviation
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(σ) were calculated for each row at each delivered dose, with row 1 located
at the beginning of the SOBP and row 4 at the end of the SOBP. A reduced
survival along the SOBP could be observed.
Table 5.2. Cell survival at HIT measurement for carbon
ion beam. Beam direction from row 1 to row 4.
Dose 1 Gy 2 Gy 4 Gy
(results in %) µ (1 σ) µ (1 σ) µ (1 σ)
Row 1 73.3 (9.1) 45.3 (10.5) 14.4 (6.6)
Row 2 75.6 (16.2) 47.1 (12.6) 10.0 (1.6)
Row 3 72.1 (8.9) 55.2 (14.1) 6.9 (1.4)
Row 4 56.9 (7.1) 46.5 (10.5) 4.7 (2.6)
The same process was repeated for the cells irradiated with proton beams.
The results can be found below (Table 5.3). One might notice that for protons
a reduced survival is obtained along the SOBP.
Table 5.3. Survival at HIT measurement for proton beam.
Beam direction from row 1 to row 4.
Dose 1 Gy 2 Gy 4Gy
(results in %) µ (1 σ) µ (1 σ) µ (1 σ)
Row 1 108.1 (4.9) 83.1 (14.1) 38.9 (7.4)
Row 2 104.6 (4.9) 69.8 (9.2) 45.5 (0.4)
Row 3 111.6 (6.3) 71.5 (23.4) 41.8 (7.2)
Row 4 98.2 (21.6) 68.0 (6.9) 34.6 (2.6)
By optimising (as described by Equation 2.3) with respect to the cell survival
data in Tables 5.2 and 5.3, survival curves for both ion types at different row
positions were obtained (Figure 5.5).
Since the absorbed dose in all rows are the same, the observed differences
are due to the difference in LET along the beam path. This explains why the
cell survival obtained at row 4 is significantly lower than the other rows. The
difference between row 3 and row 4 with proton beam is smaller than for the
carbon beam because the variation of LET is smaller compared with carbon
beam.
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Figure 5.5. Clonogenic cell survival curves at different row positions which are
indicated by the number shown in the legend after each particle type. The
experiment results are represented (x - carbon cell survival;  - protons cell
survival).
Experiment 2 - Viability Study of the Phantom for Radiobiological
Studies
The procedure of the first experiment was repeated for the second experiment.
The carbon cell survival is shown in Table 5.4 and (Table 5.5). Reduced survival
can be noted along the SOBP (two central rows).
Table 5.4. Cell survival obtained from measurements for carbon ions
beam during second biological experiment at HIT. Beam direction
from row 1 to row 4.
Dose 1.0 Gy 1.5 Gy 2.0 Gy 4.0 Gy
(results in %) µ (1 σ) µ (1 σ) µ (1 σ) µ (1 σ)
Row 1 63.9 (4.2) 58.7 (3.2) 47.9 (5.2) 12.0 (1.6)
Row 2 59.4 (2.8) 50.7 (7.9) 38.2 (3.3) 6.4 (1.8)
Row 3 55.9 (1.2) 48.3 (4.3) 35.1 (1.6) 5.0 (1.6)
Row 4 62.8 (6.3) 59.4 (11.7) 45.1 (2.6) 11.8 (3.3)
Both Tables 5.4 and 5.5 show the mean (µ) survival, taking into account the
obtained survival in the control sample by calculating the plating efficiency and
one standard deviation (σ). Similar to previous experiment, the cell survival
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in row 3 (which in this experiment is the last row fully inside the SOBP) is
significantly lower than the other rows. As expected, this effect is more evident
in the carbon beam data due to the higher LET variation.
Table 5.5. Cell survival obtained from measurements for protons
beam during second biological experiment at HIT. Beam direction
from row 1 to row 4.
Dose 1.0 Gy 1.5 Gy 2.0 Gy 4.0 Gy
(results in %) µ (1 σ) µ (1 σ) µ (1 σ) µ (1 σ)
Row 1 63.2 (1.2) 61.8 (7.9) 50.3 (1.0) 25.7 (3.7)
Row 2 56.3 (6.3) 50.0 (2.1) 40.6 (5.4) 21.9 (2.8)
Row 3 46.5 (4.3) 46.5 (4.3) 38.5 (2.8) 19.4 (1.6)
Row 4 72.2 (3.2) 68.1 (10.5) 51.0 (5.2) 28.5 (1.0)
In addition to the ion irradiations, X-ray survival was also obtained during
this experiment(Table 5.6) and this data was used to obtain the fitted curves
(Figure 5.6).
For X-rays, radiosensitivity parameters of 0.25± 0.06 for α and 0.02± 0.01
for β were obtained. For carbon ions only the α parameter was used and the
following parameters were obtained: 0.41± 0.03, 0.51± 0.03, 0.67± 0.03 and
0.44±0.03 Gy−1, for row 1, 2, 3 and 4 respectively. And for protons, 0.38±0.03,
0.40± 0.09, 0.47± 0.05 and 0.32± 0.003 Gy−1.
So as to better evaluate the results, the two middle rows of multi-well plates
were re-plotted (Figures 5.8 and 5.7). Those rows were chosen owing to the fact
they had the largest difference in survival and therefore, if there was evidence
Table 5.6. Cell survival obtained from
the irradiation at DKFZ measure-
ments for X-Rays beam.
Dose Mean Survival (1 Stdev)
1.0 Gy 82.5 (9.1)
2.0 Gy 45.8 (4.0)
3.0 Gy 37.8 (6.9)
4.0 Gy 33.2 (2.0)
6.0 Gy 10.6 (4.7)
8.0 Gy 3.7 (1.3)
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Figure 5.6. Fit of cell survival curves for different radiation types and different row
positions. The experiment results have also been plotted (x - carbon cell survival;
 - protons cell survival; N for X-rays) - Each colour represents a different row.
Beam direction from row 1 to row 4.
of the effect of the LET contribution, this is where it would be most evidently
noticeable. The calculated fitting with its uncertainties are plotted below.
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Figure 5.7. Cell survival curves plus survival data for different ion types for row
2. (N - carbon cell survival;  - protons cell survival; x for X-rays). The blue
coloured bands representthe uncertainty of the fitted parameters. Light-blue for
protons, dark for carbon and grey for X-rays.
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Figure 5.8. Cell survival curves and survival data for different ion types for row
3. (N - carbon cell survival;  - protons cell survival; x for X-rays). The green
coloured bands representthe uncertainty of the fitted parameters. Light-green for
protons, dark for carbon and grey for X-rays.
5.4.2 RBE Estimation
The RBE20 (RBE at 20% cell survival) for each well was calculated from the
fitted parameters.
Figure 5.9 shows the calculated RBE20 with its 95 % CI (Equation 2.4) for
the complete radiobiological experiment. The obtained RBE20 and RBE10 are
presented in Table 5.7.
Table 5.7. Calculated RBE at Different Survival Fractions.
Dose RBE20 RBE10
[95%CI] [95%CI]
Row 1 12C 1.48 [1.35; 1.63] 1.35 [1.27; 1.45]
Row 2 12C 1.93 [1.66; 2.29] 1.75 [1.57; 1.97]
Row 3 12C 2.02 [1.71; 2.45] 1.83 [1.62; 2.09]
Row 4 12C 1.50 [1.38; 1.63] 1.36 [1.28; 1.45]
Row 1 1H 1.05 [1.01; 1.11] 0.95 [0.92; 0.99]
Row 2 1H 1.22 [1.15; 1.30] 1.11 [1.05; 1.15]
Row 3 1H 1.33 [1.22; 1.46] 1.21 [1.14; 1.29]
Row 4 1H 0.99 [0.95; 1.04] 0.91 [0.88; 0.94]
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Figure 5.9. Calculated RBE20 for the viability study for both protons and carbon
ions. The error bars represent the 95% confidence interval and were calculated
taking into account biological and dosimetrical uncertainties. The red area
represents the positioning of the SOBP along the multi-well plate.
5.4.3 LET-RBE Variability
From the obtained cell survival, the LET-RBE variation was evaluated. The
optimised fitted survival curve and its parameters were obtained from the
cell survival data. A correlation between RBE and dose was obtained from
Equation 5.3. This process was repeated for different LET values.
Figures 5.10 and 5.11 show the obtained LET-RBE-Dose variability for
carbon and proton ions respectively.
The RBE must reduce with increasing dose. As expected at near-zero doses,
the quadratic dose terms can be neglected and Equation 5.3 becomes:
αLdL = αHdH (5.4)
leading to:
RBE → RBEmax = dL
dH
= αH
αL
(5.5)
Similarly, at exceeding high doses, the quadratic terms dominates:
CHAPTER 5. BIOLOGICAL MEASUREMENTS 127
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
Dose (Gy)
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
R
B
E
_1
0
Carbon RBE dose variation for different LET
LET=119 keV.µm−1
LET=55 keV.µm−1
LET=33 keV.µm−1
Figure 5.10. Calculated RBE-LET-Dose variability for carbon ions in the phantom
viability study.
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Figure 5.11. Calculated RBE-LET-Dose variability for protons in the phantom
viability study.
βLd
2
L = βHd2H (5.6)
and:
RBE → RBEmin = dL
dH
=
√
βH
βL
(5.7)
The observed effect is increased with the increase of the LET. Similar
behaviour has been discussed in the literature (Jones 2015a; Jones et al. 2009).
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5.4.4 Correlation between Physics and Biology
By being able to assess the dose deposition along the phantom (Chapter 4)
and the cell survival presented in this chapter, I was able to evaluate the true
capability of the phantom. Figure 5.12 correlates the different cell survival
obtained in relation to well position and dose deposition.
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Figure 5.12. Correlation of dose profile and cell survival. Cell survival is placed
alongside well position and depth dose profile. Higher dose deposition yields
lower survival. The difference in cell survival between position 2 and 3 is due to
LET contributions as described before. The different shaded areas represent a
different well position.
Cell survival is placed alongside well position and depth dose profile, and,
as expected, I found that higher deposited doses yielded lower cell survival.
In this figure, it is also possible to note the effect of LET variation, even if
not statistically significant, in cell survival between well positions 2 and 3. In
the previous section, I compared the effect of the different LET averaging. An
overforeseen problem which occurred during these measurements was that, by
reducing the SBOP to cover only the second and third wells, no constraint was
set for the fourth well leading to the dose not as low as expected. The variation
of this dose deposition can also be explained by the statistic set at the MC
simulations.
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5.5 Discussion
The enhanced biological effects of ion beam therapy using carbon or proton ions
has been discussed extensively (Barazzuol et al. 2013; Britten et al. 2013; Combs
et al. 2012; Niemantsverdriet et al. 2012; Demizu et al. 2014; Elsaesser et al.
2010; Goodhead 1999; Mitaroff et al. 1998; Paganetti 2014; Scholz 2000; Schulz-
Ertner et al. 2007; Tinganelli et al. 2013), but in order for optimal benefits to
be achieved, it is imperative to correctly understand the biological effects of
irradiation on the treatment outcome and compare it with conventionally used
X-rays. This chapter investigated the effects of different radiation types (carbon
ions, protons and X-rays) for a specific human cell line (NSCLC A549) through
the evaluation of clonogenic cell survivals. The proposed set-up used in this
work is different from the ones found in the literature since, in this instance, a
more clinical approach was adopted. By the phrase a more clinical approach, I
am referring to the cell orientation in respect to the beam, as described in the
Methods Section. As discussed by Paganetti 2014, there is increased interest in
evaluating the relationship between LET and RBE in clinical type conditions.
The survival results were transformed into RBE estimations. The Particle
Irradiation Data Ensemble (PIDE) database (Friedrich et al. 2013) contains
results of in-vitro cell survival experiments gathered in a literature survey, which
were performed pairwise after irradiation with photons and some ion species.
The dose response curves are expressed by the linear-quadratic parameters.
Initially, I compared my results with the ones obtained for all lung cancer
cells since the low number of available results with the same cell line used in
this thesis. The results can be seen in Figure 5.13. No experimental result is
available for protons for these chosen cell lines in the PIDE database.
Subsequently, I separated the results in respect to the different ion types
used during the experiments, but this time plotting all available cell line results,
Figures 5.14 and 5.15 compare the calculated RBE in my experiments to all
available cell lines in the PIDE database.
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Figure 5.13. Obtained RBE10 versus LET for the cell line used and other different
lung cell lines over different experimental results from PIDE database (Friedrich
et al. 2013) with protons and carbon ion beams. No experimental results are
available for protons for these chosen cell lines in the PIDE database.
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Figure 5.14. Obtained RBE10 versus LET for different cell lines over different
experimental results with carbon ion beams from the PIDE database (Friedrich
et al. 2013).
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The comparison with the PIDE database shows that carbon and proton
beams were found to be more effective in killing cells in culture than photons
(i.e. RBE > 1.0), which is consistent with my results. Although the calculated
effectiveness of my experiments are within these literature results, when com-
pared to the cell line used (all lung cancer cells were plotted in Figure 5.13),
the killing efficiency obtained by my phantom were lower in respect to the
LET in comparison to the literature for the cell line used, for example nearly 3
times the efficiency was reported for carbon beams (Ghosh et al. 2011) and 2
for protons (Wera et al. 2013), while my results shows a 2 and 1.2 times more
effectiveness respectively for carbon and protons.
In order to evaluate the reasons behind the differences from my experimental
result and the ones found in the literature with similar cell line, the contribution
of the LET to effectiveness had to be studied. Evaluation of the variation of
the LET along the beam path was necessary to evaluate the contribution of the
LET to cell survival. Figure 5.16 shows the calculated dose averaged LET for
both carbon ions (right) and protons (left). These LET values were calculated
by the MC simulations using built in functions.
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Figure 5.16. Calculated LETd map for carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The dose averaged LET are in keV/um.
Figure 5.9 shows the difference between the calculated RBE20 at different
positions along the SOBP. An increase in RBE is observed which corresponds to
an increase in average LET as previously described in the literature (Paganetti
2014; Ghosh et al. 2011; Yoshimoto et al. 2015).
From the results it is possible to observe an increase of RBE between the
two central wells (Figure 5.9). Although this increase of RBE along the wells
is not statistically significant: 1.92 [1.66; 2.29], 2.02 [1.71; 2.45] for carbon ions
and 1.22 [1.15; 1.30], 1.33 [1.22; 1.46] for protons. However by looking at Figure
5.9 and the LET distribution (Figure 5.16), a larger LET effect is demonstrated.
The reason for the reduced effect, or contribution of the LET variation, is
related to the size of the different wells. The effect shown by the cells depends
on the average of the LET along each well. If a profile is taken as in Figure
5.16, and the average LET is calculated according to the different well size, it
can be noted that there is a small variation in the LET for the currently well
plate used (Figure 5.17).
Figures 5.17 to 5.21 show the effect of the spatial resolution of the multi-well
plate in the variation of the average LETd.
It is important to mention that changing the bin size or the length of
the SOBP has the same effect, i.e. by increasing the size of the bin (or the
diameter of the well in the multi-well plate), the average LETd per bin decreases
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Figure 5.17. Calculated LETd map for carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The averaged LETs were calculated for the 20mm well diameter.
The dose averaged LET are in keV/um.
and the variation between the different depths is reduced. The same effect is
noted by reducing the size of the SOBP. This explains why the data from the
first experiment. In the first and last row in the SOBP the RBE obtained are
statistically different in contrast to the result obtained in the second experiment.
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Figure 5.18. Calculated LETd map for carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The averaged LETs were calculated for the 1 mm well diameter.
The dose averaged LET are in keV/um.
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Figure 5.19. Calculated LETd map for the carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The averaged LETs were calculated for the 2 mm well diameter.
The dose averaged LET are in keV/um.
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Figure 5.20. Calculated LETd map for the carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The averaged LETs were calculated for the 5 mm well diameter.
The dose averaged LET are in keV/um.
As discussed in previous chapters, dosimetric uncertainties affect the results
by either not being able to correctly evaluate the dose profile, or by disturbing
the beam which will irradiate the cells. This leads the absorbed dose in the
cell compartment being wrongly reported which weakens the biological results.
In respect to the correlation of cell survival and dose profile represented
in Figure 5.12, the phantom is able to reproduce cell survival in respect to
the dose deposition. This reproducibility is also seen for the different doses in
Figure 5.22.
As mentioned, other groups use set-ups that are also capable of evaluating
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Figure 5.21. Calculated LETd map for the carbon ions (left) and proton beams
(right). The image represents a slice through the central position in the phantom/
irradiation field. The averaged LETs were calculated for the 10 mm well diameter.
The dose averaged LET are in keV/um
the beam delivery. The closest to this capability present in the literature is
the work of Mitaroff et al. 1998 and Bert et al. 2010. Figure 5.23 present the
results obtained by such phantoms. The set-up presented by Barazzuol et al.
2012 would correctly describe the dose profile in passive scattering systems
which is not the case for the work presented in this thesis.
The main drawback of these designs, as described previously in Table 2.2,
is the inability to perform multiple irradiations in the same cell preparation
batch (which could potentially remove the huge variability in cell survival),
or to obtain the dosimetric information without disturbing the beam path, as
presented in the work by Mitaroff et al. and Bert et al. The work by Bert et
al. set forth the benefits of using commercial tools for biological irradiations,
such as the reduced reported uncertainties, but failed to provide the in-beam
dosimetry which can be obtained by my design. The work of Mitaroff et al., in
addition to not using commercially available tools for cell plating, uses detectors
with a higher uncertainty for ion beams (protons and carbon).
The main novelty of my design is that these two limitations in the final
dosimetric evaluation of the phantom and cell compartment were accounted
for during the phantom development (Chapter 3). My phantom is also able to
accommodate different detectors for in-beam dosimetry.
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Figure 5.22. Correlation of dose profile and cell survival for different irradiation
doses. Similar to Figure 5.12, these plots show the reproducibility of the phantom
in correlating cell survival and dose deposition. Plots for different doses at the
SOBP, from 1.5, 2.0 and 4.0 Gy respectively, top to bottom.
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Calculation 
Detector Measurements 
Biological Measurements
Figure 5.23. Correlation of dose profile and cell survival found in the literature.
Similar to the result obtained by my proposed design higher dose deposition
yields lower survival. The different dose at entrance, target area and exit dose can
be clearly seen. Modified figure from Mitaroff et al. 1998. TL response represent
the thermo-luminescence detectors
5.6 Conclusion
The use of ion beams (protons included) is initially motivated by the selective
depth-dose profile, which is primarily advantageous for treating targets close
to organs of risk. In addition to this superior dose delivery conformity, the
biological effectiveness of ions is also known to be superior in comparison to
photon irradiation, either represented by the supported constant 1.1 RBE value,
for protons, or by the variable increased RBE as obtained by different biological
experiments and used clinically by mathematical models. A recent review
(Tommasino and Durante 2015) summarises that the complexity contained
in the RBE parameter might be drastically underestimated by the use of a
constant value of RBE. This therefore demonstrates the need for multiple cell
irradiation experiments to correlate the responses from different radiation types.
The aim of this chapter was to study the viability of the phantom to perform
these much needed radiobiological experiments. This was done by evaluating
CHAPTER 5. BIOLOGICAL MEASUREMENTS 138
both the biological effectiveness (RBE estimation) for different radiation types
(protons and carbon ions) and the contribution of the LET to this effectiveness,
and more importantly, by evaluating the correlation of cell survival response
and deposited dose.
During the RBE estimation, similar behaviour as contained in the literature
was obtained. I was able to show that using the phantom I could obtain a
higher biological effectiveness for both protons and carbon ions in comparison
to photons. As expected, the final effectiveness was lower, due to the LET
distributions, averaging a large range of LET along the well area which is not
the case for current radiobiological experiments. The initial assessment of the
LET-RBE-Dose demonstrated that it is possible to use the cell survival data
obtained with the phantom and perform further investigations within the same
irradiation set-ups. This allows for multivariate analysis of the cell survival
with fewer irradiations. Furthermore, the use of commercially available cell
culture tools used as inserts in the phantom allow for multiple irradiations
within the same period, thereby reducing the number of irradiations and the
introduction of biological uncertainties.
In conclusion, the design showed that it was capable of benefiting from the
use of commercial tools for performing multiple cell irradiation. It is also able
to accommodate the most accurate clinically available dosimeters, and by doing
so, it is able to accurately correlate cell survival and deposited dose.
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Chapter 6
Overall Conclusion and Outlook
In complex techniques such as protons or ion beam therapy, the success or
failure of the treatment is determined by several factors relating to physical
properties, understanding of biological properties and limitations arising from
the delivery of the treatment. In this context, a precise and consistent set
of dosimetric tools for radiobiological experiments has a clear impact on the
efficiency of protons and ion beam therapy, as it reduces uncertainties in further
biological and clinical studies. This thesis provides an insight into the research
and development towards the construction and testing of a biological dosimetric
phantom for radiobiological experiments.
A literature review was performed in order to evaluate the need for such a
device and its relevance. It was possible to conclude that in order to improve our
knowledge of enhanced biological effectiveness, which is necessary to support
clinical proton and ion beam applications, more dedicated tools needed to
be developed. This is particularly true in cases where there are observed
disadvantages with some experimental set-ups that can be reduced, such as
associated dosimetric and biological limitations with the chosen detector or
biological compartment. A phantom with dosimetric information about the
delivered beam would allow radiobiological experiments to achieve the necessary
reliability and reproducibility (Desrosiers et al. 2013). The main advantage of
such devices is the precision in which dose and cell survival can be correlated.
To my knowledge, my phantom is the only radiobiological phantom that has
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had both its physical (dosimetric) and biological capabilities as well as possible
limitations evaluated during the design stages. All that in a device which is
easy to use and transportable.
A comprehensive overview of the limitations present in the current radiobi-
ological set-ups was developed during the initial design stages, focusing on the
improvements that could be achieved by the proposed device.
I determined the effect that detectors and manufacturing limitations would
have on the obtained dose distributions. The MC analysis showed that 95.3%
(98.2%, 91.2, 96.5% at the centre of the SOBP and 2 cm before and after
respectively) of the points in the desired region are within the confidence
interval of 95%. A few points fell out of this confidence interval, which could be
explained by statistical fluctuations and poor uniformity of the original beam
profile. Despite these rare anomalies, the results can be seen as satisfactory
since all points lie within 1.0% of the nominal value, which corresponds well with
dosimetry requirements. The only introduced limitation was the chosen material,
PMMA, but I was able to show that this limitation could be overcome (Figure
3.8) by accounting for the correct WEPL (Jaekel et al. 2001a). Confidence in the
phantom is clearly enhanced after studying its limitations. Even with different
irradiations at different facilities, the results agree remarkably well within the
uncertainties of the detector used. It may be that some systematic uncertainties
were not accurately estimated or some of them were not considered, but there
are no indications that this may have had a significant impact. Moreover, it
was demonstrated that the variation between irradiation fields did not present a
issue in this agreement. The only parameter that required further considerations
is the beam uniformity during the irradiation plan calculations.
The multivariate cell study (RBE and LET versus survival) is also notewor-
thy. Different authors have previously discussed the importance of evaluating
and correlating LET, RBE and cell survival (Sørensen et al. 2011; Jones 2015b;
Tommasino and Durante 2015; Durante 2014; Paganetti 2014). To my knowl-
edge, this is the very first study to address both biological and dosimetrical
capabilities and limitations during development of a biological phantom. By
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using the designed phantom I was able to obtain good agreement between the
obtained dose deposition measurements by ionisation chambers and TPS/MC
calculations in relation to local QA procedures at different centres (Tables 4.2
to 4.5). The desired accuracy for the dosimetric uncertaintity of the phantom
was determined to be close to 3%, limited by the relative uncertainty of the
ionisation chamber with respect to ions (Karger et al. 2010). For all performed
experiments, the average dose deviation between ionisation measurements and
dose calculations are well within this requirement, ranging from 1.05% to 2.39%.
This shows that appropriate steps had been taking to account for the different
limitations of the phantom.
In addition to its proven dosimetrical capabilities, the phantom was evalu-
ated in a radiobiological viability study. RBEs were evaluated as part of the
biological response. A superior effectiveness was obtained for both protons
and carbon ions compared to the literature (Wera et al. 2013; Ghosh et al.
2011). This phantom can be used in radiobiological experiments for survival
dose measurements and possibly to correlate irradiation dose to RBE and LET.
Improved spatial resolution by the use of smaller well sizes would be needed
in order to average the LET between smaller ranges. The performance of the
phantom was similar to other methods used, i.e. improved sensitivity was
observed for ion beams in relation to photon, but in order to compare whether
the level of this efficiency is the same, future irradiations would need to take
into account the LET at well positions.
In order to benefit fully from the capabilities described above the main
sought after feature of the phantom is its ability to correlate the physical and
biological processes. This feature was demonstrated in Figure 5.12. (Desrosiers
et al. 2013) Since the phantom was able to correctly correlate the calculated
dose distribution and therefore obtain a grid dosimetry at the cell compartment.
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6.1 Outlook
Herein an extensive, comprehensive, and systematic work was performed con-
cerning the biological dosimetric capabilities of the designed phantom. The
overall errors associated with the phantom are due to its dosimetric and radio-
biological uncertainties.
The dosimetric errors are either associated with the dose delivery, dose cal-
culation or measurement. Dose delivery errors can be introduced by limitations
in the delivery system by uncertainties in delivering the required number of
ions, and the beam position and characteristics (for example beam width and
energy). Intrinsically dose calculations are thought to be accurate, but it is
possible that systematic deviations between the model used in treatment plan-
ning and the delivered beams are present. These systematic errors originated
from uncertainties in the description of the Bragg curves or the lateral profiles,
uncertainties in the modelling of the multiple Coulomb scattering or the limited
knowledge of the fragmentation processes. Lastly, dose measurement errors are
associated with uncertainties resulting from the stability and reproducibility
of the ionisation chamber, the electrometer and setting up the phantom and
positioning the ionisation chambers within the phantom correctly.
In regard to radiobiological uncertainties, the systematic errors can con-
tribute to increased errors in the cell survival results. These uncertainties are
generally associated with handling and counting of the cell cultures and can
occur during and after irradiation. An extra limitation of the measurements
presented in this thesis is that repetition of survival per dose was taken from
the same irradiation, from different wells at the same depth. A future step is
to perform more survival measurements and evaluate whether using the same
irradiation at different wells are sufficient or if this would introduce further
errors.
In this thesis, I was able to shown that this design can be used to aid
radiobiology experiments at different centres. Dosimetric consistence is a key
requirement by guidelines from major health agencies (e.g. the National Cancer
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Institute - NCI) in order to participate at clinical trials, which are the foundation
of the much-needed evidence-based medicine. Consistency of treatments at
different sites also facilitates the transfer of results and patients between facilities
aids future research developments and possibly patient mobility with these
not so widely spread techniques. The work shown in this thesis shows the
superior dosimetrical capability of the phantom in respect to other solutions
found in the literature. The present study can contribute to the development
of radiobiological solutions and their translation into further radiobiological
experiments and clinical use. The developed phantom design can be used to
further evaluate not only the physical dose and the different treatments, but
also the varying conceptions of similar treatments used by different centres in
calculating the biological dose to the patient. Although the proposed design is
fully functional, improvements to experimental set-up can be made by:
• Increasing beam uniformity of delivered field: In order to reduce un-
certainties introduced by non-uniformities in the dose distribution the
irradiation plan can be recalculated. However, this would increase the
irradiation time and therefore more beam time would be required. An al-
ternative would be to offset these effects with different delivery techniques,
such as passive scanning.
• The radiobiological output can be improved by using higher spatial
resolution in cell survival sampling. At present the phantom survival
results are not directly comparable with results found in literature due
to the larger than average LET range used. In an effort to improve this
weakness while still maintaining the ability to evaluate the survival effect
in a mixed radiation field, the phantom has been adapted to hold different
commercially available multi-well cell plates which provides the extra
diminution required in the survival analysis. This allows multiple cell
survival assessment for different dose deposition reducing the averaging
effect of the LET variation.
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Appendix A
Phantom Description and Beam
Orientation
A.1 Phantom Description
The phantom, shown in Figure A.1, consists of a PMMA block with dimensions
of 240.0 ± 0.1 (H) x 240.0 ± 0.1 (W) x 146.0 ± 0.1 (L) mm3, machined
to accommodate a standard multi-well cell holder for cell irradiations and
ionisation chambers pinpoint detectors at different positions.
Two sets of eleven holes of 10.5-mm diameter have been drilled to different
depths in the phantom. The two sets of holes have been drilled symmetrically
to the left and the right of the beam entrance. They have been conceptually
conceived to host pinpoint ionisation chambers. The positions of the holes are
such that they populate uniformly a Spread-Out-Bragg-Peak (SOBP) of up to
12 cm long. In cases where centres did not have all the pinpoint chambers, the
empty cylindrical cavities were filled with mock chambers of the same PMMA
material. The phantom was machined to host the PTW PinPoint Model n31014,
0.015 cc volume. The shape of the deep end of each hole matches the tip of the
detector to avoid air-gap, which could affect the dose deposition. The design
enables on-line information about the requested SOBP to be obtained from the
available detector positions at the same time as cell cultures are irradiated. The
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phantom offers two options: the first concentrates on the physical properties
of the delivered beam and the second delivers biological response information.
By using the described methods, multiple irradiations can be performed at the
same beam time and on the same day. This will facilitate high-throughput
data acquisition from biological samples prepared in the desired experimental
setting.
Figure A.1. Photography of the phantom and multi-well plates.
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Figure A.2 represents a three-dimensional model of the phantom with the
detector and cell compartment positions shown.
Figure A.2. 3 dimensional model of the phantom with labelled detector and cell
compartment locations.
A.2 Beam Orientation
As described previously, one of the phantom’s uniqueness is the orientation of
the beam in relation to the cell plate. As shown in Figure A.3, the beam is
parallel to the cell plate and therefore the radiobiological output is obtained at
variable beam positions along the beam.
Figure A.3. Beam representation in respect to the phantom and cell plate.
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Appendix B
FLUKA User Routines
B.1 Modified User Routine
In addition to the DDS description, FLUKA default user routine (which
work as personalised computation scripts) was adapted in order to be able to
correctly interpret irradiation plan files into the simulations. In FLUKA, in
order to have different irradiation descriptions (orientation, starting location
and particle fluence), a built-in function called source must be used. Users are
able to personalise this function for their individual case. At a typical ion beam
irradiation plan, the beam is divided into varying multiple starting locations
and particle number per location.
This appendix describes the FLUKA user-routine that was modified in
order to simulate irradiation plans in FLUKA. The initial part of the code was
not modified.
The information contained in the irradiation plan was read as follows:
READ(RSTLUN, ∗) CDUMMY1, PATIENT_ID
READ(RSTLUN, ∗) CDUMMY1, CDUMMY2
READ(RSTLUN, ∗) CDUMMY1, PROJECTILE
WRITE(LOGLUN, ∗ ) ’ p r o j e c t i l e : ’ ,CDUMMY1, PROJECTILE
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READ(RSTLUN, ∗) CDUMMY1, CHARGE
WRITE(LOGLUN, ∗ ) ’CHARGE: ’ ,CDUMMY1,CHARGE
IF (CHARGE .EQ. 1) THEN
RATIO_U=1.00727647D0
WRITE(LOGLUN, ∗ ) ’CONVERSION FACTOR MEV/U −> MEV’ ,
& RATIO_U
ELSE IF (CHARGE .EQ. 6) THEN
RATIO_U=ONEONE
WRITE(LOGLUN, ∗ ) ’CONVERSION FACTOR MEV/U −> MEV’ ,
& RATIO_U
ELSE
STOP ’NOT YET IMPLEMENTED FOR IONS DIFFERENT
& FROM P,12C’
END IF
READ(RSTLUN, ∗) CDUMMY1, MASS
WRITE(LOGLUN, ∗ ) ’READ mass : ’ ,CDUMMY1,MASS
READ(RSTLUN, ∗) CDUMMY1, DUMMY1
WRITE(LOGLUN, ∗ ) ’ bolus ’ , CDUMMY1, DUMMY1
READ(RSTLUN, ∗) CDUMMY1, INTDUMMY1
WRITE(LOGLUN, ∗ ) ’ r i p p l e f i l t e r ’ , CDUMMY1, INTDUMMY1
READ(RSTLUN, ∗) CDUMMY1, SUBMACHINES
WRITE(LOGLUN, ∗ ) ’LAST READ submachines : ’ ,CDUMMY1,
& SUBMACHINES
READ(RSTLUN, ∗) CDUMMY1, PARTICLE_MIN_ABS,
& PARTICLE_MAX_ABS, PARTICLE_TOTAL_ABS
WRITE(LOGLUN, ∗ ) ’LAST READ p a r t i c l e s : ’ ,CDUMMY1,
& PARTICLE_MIN_ABS, PARTICLE_MAX_ABS,
& PARTICLE_TOTAL_ABS
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Each beam energy which is represented as a individual submachine was
read.
POINTS_TOTAL = 0
DO I=1, SUBMACHINES
READ(RSTLUN, ∗) CDUMMY1, INTDUMMY1, POINT_ENERGY,
& INTDUMMY2, POINT_FOCUS
READ(RSTLUN, ∗) CDUMMY1, PARTICLE_MIN, PARTICLE_MAX,
& PARTICLE_TOTAL
READ(RSTLUN, ∗) CDUMMY1, DUMMY1, DUMMY2
READ(RSTLUN, ∗) CDUMMY1, POINTS
∗ loop over ac tua l submachine s t a r t s here
DO J=1, POINTS
POINTS_TOTAL = POINTS_TOTAL + 1
READ(RSTLUN, ∗) POINT_XY(1 ) , POINT_XY(2 ) ,
& RST_PARTICLES
Positions are converted from mm to cm as used by the FLUKA code. The
beam direction is then calculated then the orientation of FLUKA simulation
was modified to be consistent with the orientation used by the TPS.
∗ S i tua t i on @ ISOCENTER
POINT_XY(1) = POINT_XY(1)/TENTEN
POINT_XY(2) = POINT_XY(2)/TENTEN
POINT_XY(3) = ZERZER
# energy GeV/c
RST_ARRAY(1 ,POINTS_TOTAL) = POINT_ENERGY/1 .D03∗
& MASS∗RATIO_U
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# x coord inate o f RST point in FLUKA coo rd ina t e s
RST_ARRAY(2 ,POINTS_TOTAL) = ZERZER
# y coord inate o f RST point in FLUKA coo rd ina t e s
RST_ARRAY(3 ,POINTS_TOTAL) = ZERZER
# z coord inate o f RST point in FLUKA coo rd ina t e s
RST_ARRAY(4 ,POINTS_TOTAL) = RST_ORIGIN(3)
∗ c a l c u l a t e the d i r e c t i o n c o s i n e s here
∗ SWAPPED X AND Y fo r con s i s t ency with
∗ the TPS−VX PLAN
TARGET_VECTOR(1) = POINT_XY(2) − RST_ORIGIN(2)
TARGET_VECTOR(2) = POINT_XY(1) − RST_ORIGIN(1)
TARGET_VECTOR(3) = POINT_XY(3) − RST_ORIGIN(3)
R = SQRT(TARGET_VECTOR(1)∗∗2 + TARGET_VECTOR(2)∗∗2
& + TARGET_VECTOR(3)∗∗2 )
# x d i r e c t i o n co s i n e in FLUKA coo rd ina t e s
RST_ARRAY(5 ,POINTS_TOTAL) = TARGET_VECTOR(1)/R
# y d i r e c t i o n co s i n e in FLUKA coo rd ina t e s
RST_ARRAY(6 ,POINTS_TOTAL) = TARGET_VECTOR(2)/R
# z d i r e c t i o n co s i n e in FLUKA coo rd ina t e s
RST_ARRAY(7 ,POINTS_TOTAL) = TARGET_VECTOR(3)/R
∗ f o cu s i s converted from mm to cm and s to r ed
RST_ARRAY(8 ,POINTS_TOTAL) = POINT_FOCUS/TENTEN
# number o f p a r t i c l e s to s imulate
RST_ARRAY(9 ,POINTS_TOTAL) = RST_PARTICLES
Lastly, is this information (beam energy, direction and position) is linked
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to FLUKA variables for the simulation.
# Now l i n k i n g in to FLUKA va r i a b l e s :
∗ choose randomly which po int w i l l be s imulated ,
∗ i t takes in to account that each po int has a
∗ d i f f e r e n t number o f p a r t i c l e s
RAND3 = FLRNDM(DOUBLEDUMMY)
PARTICLE_RAND = PARTICLE_TOTAL_ABS ∗ RAND3
PARTICLE_SUM = ZERZER
DO I=1, POINTS_TOTAL
PARTICLE_SUM = PARTICLE_SUM + RST_ARRAY(9 , I )
IF (PARTICLE_SUM .GT. PARTICLE_RAND) THEN
ACTUAL_POINT = I
EXIT
END IF
END DO
∗ Kinet i c energy o f the p a r t i c l e (GeV)
TKEFLK (NPFLKA) = RST_ARRAY(1 ,ACTUAL_POINT)
∗ Pa r t i c l e momentum
PMOFLK (NPFLKA) = SQRT ( TKEFLK (NPFLKA) ∗
& ( TKEFLK (NPFLKA) + TWOTWO ∗ AM (IONID) ) )
CALL FLNRRN (RGAUS0)
PMOFLK(NPFLKA)=PMOFLK(NPFLKA)+WHASOU(1)∗
& PMOFLK(NPFLKA)∗RGAUS0/S2FWHM
∗ Cosines ( tx , ty , tz )
TXFLK (NPFLKA) = RST_ARRAY(5 ,ACTUAL_POINT)
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TYFLK (NPFLKA) = RST_ARRAY(6 ,ACTUAL_POINT)
TZFLK (NPFLKA) = RST_ARRAY(7 ,ACTUAL_POINT)
∗ Pa r t i c l e c oo rd ina t e s
CALL FLNRR2 (RAND1,RAND2)
XFLK (NPFLKA) = RST_ARRAY(3 ,ACTUAL_POINT)+
& WHASOU(2)∗RAND1/S2FWHM
YFLK (NPFLKA) = RST_ARRAY(2 ,ACTUAL_POINT)+
& WHASOU(2)∗RAND2/S2FWHM
ZFLK (NPFLKA) = RST_ARRAY(4 ,ACTUAL_POINT)
The main modifications to the available code focused on the interpretation
of irradiation plan information into FLUKA:
• location variables: XFLK, Y FLK, ZFLK,
• kinetics energy variable: TKFLK, and
• number of particles to be simulated: PARTICLESUM.
The code was initially provided by the Medical Physics team from CNAO,
but owing to the clinical use of CNAO simulations, their version of FLUKA
and the one used in my simulations are different. In order to make it work
in my FLUKA version, I had to update the links to the imported variable
present in this user routine. Additionally, I had to correct the simulation
reference, done with Flair, to match the TPS to orientation as the irradiation
plan are generated in this reference orientation. At CNAO and other centres,
this re-orientation is currently done during the post-processing stages.
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